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Abstract 
Medical devices have a significant negative impact on the environment. The waste generated from medical 
devices has environmental as well as cost implications. While single-use devices are responsible for rising 
quantities of medical waste and inventory costs for hospitals, reused devices tend to get involved in cases 
of reinfection and are more expensive to develop for manufacturers. Beyond the benefits and risks of single-
use and reusable devices, the imperative for a less wasteful healthcare system in the United Kingdom lies 
in the Climate Change Act, which mandates the reduction of greenhouse gas emissions by 80% from the 
1990 baseline. 
The design of these devices accounts for many of the environmental impacts that occur at the various stages 
of their lifecycles. Research in ecodesign for medical devices has so far produced more eco-efficient 
strategies which help progressively reduce the environmental impacts of devices. Based on the reports from 
the National Health Service, the current efforts at tackling the environmental impact of medical devices are 
not contributing to the reduction in emissions as required by the Climate Change Act. Eco-effective design 
is an alternative strategy for preventing waste and maximizing the value of resources used due to the rising 
pressures from regulatory authorities to reduce environmental impact, and the rising costs of pursuing a 
take-make-dispose culture, as has been observed in industries such as the automotive sector, electronics 
sector, textiles and consumer products sector. Yet its application in the medical device industry has not 
been significantly explored. Through this project, we identify the barriers and opportunities for eco-
effective design of medical devices, and propose the principles of eco-effective design of medical devices, 
providing an approach for integrating eco-effective design strategies in the design process. 
Research Question: How can eco-effective strategies be integrated in the design of medical devices? 
1. What are the barriers and opportunities to eco-effective design of medical devices? 
2. How can these eco-effective strategies be integrated in the design process? 
This study explores the barriers and opportunities to eco-effective design for medical devices in two phases. 
The first phase reviews the regulatory, practical and epistemic barriers and opportunities to eco-effective 
design of medical devices through academic literature. The second phase of this research uses mapping of 
  
4 
material flows as a method for identifying barriers and opportunities for cradle-to-cradle design of medical 
devices. Using the insights and understanding from these two phases, we developed the principles of eco-
effective design for medical devices. The principles have been validated through interviews with field 
experts 
This project investigates the regulatory, practical and epistemic barriers to eco-effective design in this 
industry, and identifies design principles to integrate eco-effective design strategies in the design process 
for medical devices.  
Keywords: Ecodesign, medical device design, cradle-to-cradle 
  
  
5 
Contents 
 
Declaration 2 
Abstract 3 
Contents 4 
List of Figures 7 
List of Tables 8 
Acknowledgements 10 
1. Introduction 11 
1.1 Motivation 11 
1.2 Background 13 
1.3 The Challenges in existing Design Methods 14 
1.4 Thesis Structure 16 
2. Literature Review 18 
2.1 Medical Device Design 18 
2.2 Ecodesign 20 
3 Methodology 25 
4  Phase 1 - Barriers and Opportunities for Eco-Effective Design of Medical Devices 29 
4.1 Review 1 - Regulatory Barriers and Opportunities 29 
4.1.1 Critical Analysis of Regulations 30 
4.1.2 Analysis 32 
4.2 Review 2 - Practical barriers and opportunities 36 
4.2.1 Analysis 37 
4.3 Review 3 - Epistemic Barriers and Opportunities 42 
4.3.1 Ecodesign for medical devices 42 
Analysis 43 
4.3.2 LCA and medical devices 43 
Analysis 45 
4.4 Analysis - Phase 1 47 
5. Phase 2 - Mapping Material Flows in Medical Device Lifecycles 49 
5.1 Structure of the map 50 
5.2 Medical device material flows 52 
5.3 Key aspects of the map 72 
5.4 Analysis - Material flow mapping 73 
6 Principles of Eco-Effective Design for Medical Devices 74 
  
6 
6.1 Lifecycle Eco-Design Framework 77 
6.1.1 Scope of application 81 
6.2 Example - Redesign of the endotracheal tube 83 
6.3 Interviews 90 
6.3.1 Suggestions 90 
6.3.2 Analysis - Interviews 92 
7 Discussion 93 
7.1 Contribution to knowledge 94 
7.2 Limitations 96 
7.3 Future Prospects 97 
8 Conclusion 98 
Appendices 101 
Appendix 1 - Ethics application confirmation 101 
Appendix 2 - Consent Forms 102 
Interviewee 1 - Dr. Patrick Moriarty 102 
Interviewee 2 - Dr. Xiaoyu Yan 104 
Interviewee 3 - Jonathan West 106 
Interviewee 4 - Gianpaolo Fusari 108 
Appendix 3 - Research Document for Interview 149 
Appendix 4 - Interview Transcripts 136 
(i) Interview with Dr. Patrick Moriarty 136 
(ii) Interview with Gianpaolo Fusari 139 
(iii) Interview with Dr. Xiaoyu Yan 141 
(iv) Interview with Jonathan West 142 
List of References/ Cited Text 150 
1 Introduction 150 
2 Literature Review 152 
3 Methodology 153 
4 Phase 1 - Barriers and Opportunities to Eco-Effective Design for Medical Devices 154 
5 Phase 2 - Mapping Material Flows in Medical Device Lifecycles 158 
6 Principles of Eco-Effective Design for Medical Devices 159 
7 Discussion 161 
Annexure 2 161 
  
7 
 
 
 
List of Figures 
Figure 1. Environmental learning cycle (Frei and Züst, 1997) 
Figure 2. Regulations and policy hierarchy structure for medical device lifecycles in England 
Figure 3. Regulations for toxicity of substances used or produced at various stages of the lifecycle of a 
medical device 
Figure 4. Regulations on management and disposal of home healthcare waste 
Figure 5. Product-life extension strategies for medical devices 
Figure 6. Regulatory barriers to looping material flows 
Figure 7. Role of decontamination in product-life extension and material recovery 
Figure 8. Stakeholder complex in medical device lifecycles 
Figure 9. Elements of the map 
Figure 10. Structure of the map 
Figure 11. Mapping the medical device resource cycles 
Figure 12. Lifecycle of a single-use disposable device 
Figure 13. Procurement strategies for medical devices 
Figure 14. Lifecycle of a rented medical device 
Figure 15. The decontamination-use cycle 
Figure 16. Algorithm for choosing the appropriate decontamination process (adapted from Royal Devon 
and Exeter, (2018)) 
Figure 17. Decontamination strategies for medical devices 
  
8 
Figure 18. Decontamination cycle for reusable medical devices 
Figure 19. Decontamination cycle for low risk of infection 
Figure 20. Decontamination cycle for intermediate risk of infection 
Figure 21. Decontamination cycle for intermediate/high risk of infection 
Figure 22. Use strategies for medical devices 
Figure 23. Lifecycles of a reusable device 
Figure 24. Lifecycle of a bioabsorbable device 
Figure 25. Disposal strategies for medical devices 
Figure 26. Ideal state of resource cycling in medical devices 
Figure 27. Principles of eco-effective design for medical devices 
Figure 28. Lifecycle eco-design framework for medical devices 
Figure 29. Parts of an Endotracheal tube (Smiths Medical, 2019) 
Figure 30. Step 1: Lifecycle Mapping 
Figure 31. Mapping the lifecycle of ET 
Figure 32. Step 2: Identify and Eliminate Toxicity 
Figure 33. Step 3: Identify Circular Design Strategies 
Figure 34. Iteration 2: Back to Step 1: Mapping material flows 
Figure 35. Ideal lifecycle of ET 
Figure 36. Systemic challenges to eco-effective design of medical devices 
  
  
9 
List of Tables 
Table 1. Medical device design processes (early stages) 
Table 2. Project requirements at the early stages of the device development process 
Table 3. Characteristics of eco-effective design 
Table 4. Regulatory barriers and opportunities to eco-effective medical devices 
Table 5. Opportunities and barriers to product life extension and material recovery strategies 
Table 6. Eco-design frameworks, methods, tools for medical devices 
Table 7. LCA for medical devices 
Table 8. Summary - Phase 1 
Table 9. Three-point Lifecycle Eco-Design Framework 
Table 10. Hierarchy of design strategies for eco-effective medical device design 
Table 11. List of Interviewees 
Table 12. SWOT analysis of lifecycle design framework 
Table 13. Barriers and opportunities for eco-effective design of medical devices 
 
  
  
10 
 
 
Acknowledgements 
This project would be far from its current stage of progress without the valuable inputs, comments, 
feedback, discussions, arguments and completely unrelated banter from the many people knowingly or 
unknowingly involved in its development. I would like to specifically acknowledge the following people. 
First and foremost, my family. Their constant support, and unhindered motivation kept me going through 
this journey with very few challenges. I would like to thank my principal supervisor Professor Stephen J. 
Wang, my secondary supervisor Professor Saeema Ahmed-Kristensen and Head of Department Professor 
Ashley Hall for introducing me to the field of design research, and guiding me through this project. It has 
been a very enriching experience and I hope to continue on this path for many years to come. I would also 
like to thank Professor Patrick Langdon and Professor Sam Jacoby for their valuable feedback in the viva, 
and the revisions they suggested, which have significantly improved my understanding of writing research 
as was explored through multiple versions of this thesis. 
I would like to thank my close friends and colleagues in post-graduate research at the Royal College of Art 
for helping me demystify research and be smarter with my work. I would like to thank Tigzi for all the 
support, inspiration and level-headed advice that pulled me out of tough situations, and made this journey 
a fun and entertaining experience.  
I would like to thank Rachel, and the administrative staff in the School of Design for being a one-stop 
solution for most of my problems. I would also like to thank Praveen, Professor Rao and Bala Uncle for 
their continued support and encouragement. 
Lastly, I would like to acknowledge the Royal College of Art and their support staff for ensuring that I 
never took anything for granted, and was kept on my toes for every-basic-necessity. 
  
11 
 
 
 
1. Introduction 
The first chapter of this thesis provides a glimpse at the various contextual and structural elements that 
build the foundations for this research. The first section takes a look at the motivations for venturing into 
this subject and using research as a medium for developing a deeper understanding. This section delves into 
my prior experience in the field of medical device design and how this experience led to an interest in 
design research and the research questions being explored in this thesis. The second section provides a brief 
understanding of the problem of environmental impacts due to medical devices. The third section delves 
into the design problem within the discourse of rising environmental impacts of medical devices, and 
explains the research questions being addressed through this study. The fourth section provides the overall 
structure of this thesis and a chapter-wise break-up of the contents.  
1.1 Motivation 
My interest in design for healthcare started in the third year of my industrial design Bachelor’s programme 
at the National Institute of Design, India. With Gujarat being one of the leading harbours of diabetic patients 
in the World, I decided to work on a Diabetes Management System for my 5th semester project that would 
help Type 1 and 2 Diabetes patients. By understanding the complexities of the pathophysiology of Diabetes 
Mellitus, I became fascinated by the process of designing a patient-centered solution using wearable devices 
and the concept of Internet of Things. The project was further presented as a paper at the India HCI 
conference (Kumar, 2014). The challenge that came with solving real-world healthcare problems excited 
me, and sparked a new interest in design. 
Two years later I received an opportunity to develop a surgical device as part of my graduation project. The 
company that sponsored it was a start-up developing innovations for affordable and accessible healthcare 
in India, and this was one of their first products. The project involved developing a surgical toolkit from a 
provisional patent to the alpha prototype, and gave me the hands-on experience of testing and product 
development in a lean team consisting of a clinician, a designer, and a biomedical engineer. The experience 
convinced me that I wanted to continue working in design for healthcare. The product went on to be 
launched a year later, boosting my confidence in having the capability to develop meaningful solutions to 
unmet clinical needs (InnAccel, 2017). 
From then on, I continued to work in this field, consulting small and medium enterprises in the development 
of healthcare services and medical devices. The journey was full of challenges, because a significant amount 
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of time went into educating clients about the role of design in the development of medical devices. Although 
the projects were lengthy, clients would use design as a touch-up solution to decorate crude functionality. 
Hence the design phase would be particularly short. I learned a lot from my projects about the role of design 
in the creation of innovative solutions, the need for a collaborative multi-disciplinary team to develop 
medical devices, and the complexities involved in developing a marketable solution.  
Through this journey I also understood the priorities that were uniquely important to stakeholders in the 
industry. In one such project with a global humanitarian aid organization, we were developing an inclusive 
pregnancy kit, allowing blind women to discreetly test their pregnancy. The device, which used chemical 
reagents and electromechanical components, was a novelty in this category of products. But the business 
model that made the most financial sense was to make the product single-use disposable. This particular 
project struck me from the perspective of the potential waste of components and reagents due to this one 
device. I developed an interest in understanding the wasteful implications of single-use disposables in the 
medical device industry. I also developed an interest in understanding the impact of design on climate 
change, and how my own practice in this field could be improved so that it benefits those who need care, 
while not contributing to an environmental burden.  
With this motivation, I decided to pursue research to further understand how my practice as a medical 
device designer impacts the environment, and how this practice of industrial design could be improved, 
balancing the use of natural resources with careful preservation of the ecosystem. 
The interdisciplinary nature of research in ecodesign for medical devices, and the far removed sense of 
perspective that it required as compared to design research for urban lifestyles and commercial consumer 
goods, made the process of finding potential supervisors extremely difficult. While professors at various 
well reputed institutes were interested in certain aspects of this research, it was not easy to find academics 
with the necessary resolve, interest and experience to guide this research. Fortunately, the head of design 
research and my supervisor at the Royal College of Art agreed to give this project a chance, and with this 
opportunity, I began my journey in design research. 
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1.2 Background 
Medical devices have a significant negative impact on the environment. It is estimated that the healthcare 
sector in the United States (US) contributes almost 10% of their total greenhouse gas emissions (Eckelman 
and Sherman, 2016). In the United Kingdom (UK), medical instruments and equipment are responsible for 
around 13% of the greenhouse gas (GHG) emissions of the healthcare sector, exceeding 3.5 MtCO₂e per 
year (NHS England, 2018). In fact, Hawkes (2012) identified that almost two-thirds of the emissions 
generated by the National Health Service (NHS) come from sources such as pharmaceuticals, medical 
devices and the supply chain, which are not directly controlled by the NHS. Worldwide, the amount of 
waste created per hospital patient per day ranges from 0.44 kg in Mauritius to 8.4 kg in the United States 
of America, with European countries tending to be between those two extremes (UK 3.3 kg, Germany 3.6 
kg and France 3.3 kg) (Minoglou et al., 2017). 
Waste generated from medical devices has environmental as well as cost implications. Hoenich et al. (2005) 
found that a dialysis unit treating 100 patients generates 39 metric tons of waste annually, the disposal cost 
of which ranges between £180 to £320 per ton. A significant component of the waste is polyvinyl chloride 
(PVC), which not only has adverse health implications for some patients, but also generates carcinogens 
upon incineration, which is the most viable disposal option for much of this waste (Windfeld and Brooks, 
2015). The cost implications also act as a double-edged sword for healthcare providers. Single-use medical 
devices not only increase inventory requirements of healthcare providers, but also add to the cost 
implications of waste management (Zygourakis et al., 2017). Furthermore, the greenhouse gas emissions 
from healthcare are estimated to be responsible for future health damages of 123,000 to 381,000 disability-
adjusted life-years due to the annual GHG emissions from healthcare (Eckelman and Sherman, 2018). 
Although there are notable concerns around resource waste, health and environmental impacts of single-
use disposables, it is important to acknowledge the concerns around reusable medical devices as well before 
counting them as the obvious solution. Reuse of single-use and reusable medical devices has produced 
multiple adverse events of reinfections and disease outbreaks which not only burden healthcare providers 
with greater requirements of care, but also invite litigations for negligence (Shuman and Chenoweth, 2012). 
In some cases, reusable devices also required increased time and processing requirements, which generate 
additional costs for hospitals (Bouthors et al. 2019).  
The problem of ecological impact of medical devices clearly pervades various phases of their lifecycle, 
including design and manufacture, procurement, inventory management, use and disposal. Thus, a broader 
understanding of solution spaces is required to tackle this problem. 
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1.3 The Challenges in existing Design Methods 
Beyond the benefits versus risks of single-use and reusable devices, the imperative for a less wasteful 
healthcare system in the UK lies in the Climate Change Act (legislation.gov.uk, 2008), which mandates the 
reduction of greenhouse gas emissions by 80% by 2050 from the 1990 baseline. Based on the progress 
made so far in reducing GHG emissions, the NHS is well off the intended GHG emission reductions in 
order to be on course for the 80% reduction mandate (NHS England, 2018). With a rising population, and 
increasing life expectancy rates, the NHS is poised to expect a significant increase in demand for healthcare, 
which will increase the need for medical devices, and consequently generate higher quantities of waste if 
the current system pervades (Thorlby, 2013). 
There are multiple points of intervention in the lifecycle of a medical device to reduce the GHG emissions 
including procurement (Ison and Miller, 2000), inventory management (Ahmadi et al. 2018), procedure 
management (Caloyeras et al., 2018), and waste management (Windfeld and Brooks, 2015), but it is 
evidenced that 70-80% of downstream decisions in the lifecycle of a product are influenced by the design 
decisions at the early stages of the design process (Ramani et al. 2010; Jeswiet and Hauschild, 2005). The 
approach to design with an emphasis on reducing or eliminating the negative impact on the environment 
falls under the concept of eco-design, first defined by Van der Ryn and Cowan (1996, p. 33) as “any form 
of design that minimizes environmentally destructive impacts by integrating itself with living processes.”. 
Eco-design broadly falls under two categories, one advocating for a progressive reduction in environmental 
impact, namely eco-efficient design (Ehrenfeld, 2005), and the other advocating for a more proactive 
stance, focusing on factoring ecological considerations in the very act of design itself and generating a 
positive environmental impact, namely eco-effective design (Frei and Züst, 1997; Braungart et al., 2007). 
An eco-effective design approach, focuses on maximizing value in resources not just in their current state, 
but also preventing the generation of waste as such (Frei & Züst, 1997). The cradle-to-cradle philosophy is 
one such approach which has seen a tremendous uptake in many industries as a model for eco-effective 
design ( Braungart et al., 2007). Eco-effective design is a strategy for preventing waste and maximizing the 
value of resources used. Its application in the design of products is particularly relevant due to the rising 
pressures from regulatory authorities to reduce environmental impact, and the rising costs of pursuing a 
take-make-dispose culture, as has been observed in industries such as the automotive sector, electronics 
sector, textiles and consumer products sector (Kumar and Putnam, 2008; Fernando and Evans, 2016). Yet 
its application in the medical device industry has not been significantly explored. This has been further 
validated by Kumar et al. (2017) in their study of industrial system dynamics for environmental 
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sustainability in the UK medical technology sector. Through this project, we explore the lack of eco-
effective design strategies for medical devices by addressing the following research question. 
Research Question: How can eco-effective measures be integrated in the design of medical devices? 
1. What are the barriers and opportunities to eco-effective design of medical devices? 
2. How can these eco-effective strategies be integrated in the design process? 
The research investigates the barriers and opportunities to eco-effective design for medical devices over 
two phases. The first phase involves three sets of literature reviews to identify regulatory, practical and 
epistemic barriers and opportunities to eco-effective design of medical devices. The second phase of this 
research was conducted using mapping of material flows as a method for identifying barriers and 
opportunities for cradle-to-cradle design of medical devices. Using the environmental learning cycle as a 
base for developing eco-effective design strategies as suggested by Frei and Züst (1997), we conducted a 
preliminary material flow mapping using secondary data to define the system boundaries and validate how 
the regulations could affect the implementation of technical and biological cycles. This approach helped 
validate some of the findings from the first phase and identify new opportunities and barriers to eco-
effective design of medical devices. Based on the findings from phases 1 and 2, we proposed the principles 
of eco-effective design for medical devices. These principles provide a foundation for approaches to 
integrate eco-effective measures in the design of medical devices. The principles were used to propose one 
instance of a framework for identifying and applying eco-effective design strategies on medical devices. 
The framework was elaborated with an example of the redesign of an endotracheal tube and suggested what 
the ideal eco-effective cradle-to-cradle scenario in a medical device could resemble. The framework was 
further tested through face-validation interviews, and the feedback from the experts helped validate the 
underlying principles of the framework and their relevance to integrating eco-effective measures in the 
design of medical devices The research identified regulatory, practical as well epistemic barriers to eco-
effective medical device design, and proposes a set of principles of eco-effective design for medical devices, 
giving device manufacturers an approach to factor eco-effective criteria at the early stages of the design 
process.  
This project strives to contribute knowledge in eco-effective design for medical devices. The barriers 
identified are possible reasons for the lack of research in eco-effective design in medical devices, while the 
opportunities identified are potential avenues that can be explored for integrating eco-effective measures in 
the design of medical devices, considering the pressures of the Climate Change Act (2008) and the need 
for a more proactive approach towards mitigating the environmental impact of medical devices. 
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1.4 Thesis Structure 
This thesis is structured in eight chapters as explained below. 
The first chapter gives an overview of the research topic, starting with a description of the motivation to 
pursue research in this field. The second section provides a brief understanding of the problem of 
environmental impacts due to medical devices. The third section delves into the design problem within the 
discourse of rising environmental impacts of medical devices, and explains the research questions being 
addressed through this study. The fourth section provides the overall structure of this thesis and a chapter-
wise break- up of the contents. 
The second chapter provides a brief understanding of the relevant concepts of medical device design and 
ecodesign. This chapter is intended as a primer for this study. The first section entails an understanding of 
the medical device design process and the lack of requirements which could ensure minimum 
environmental impact from the devices. The second section details the concept of ecodesign, more 
specifically looking at eco-effective design and its relevance to this project.  
The third chapter provides an understanding of the methods and methodology for this study.  
The fourth chapter develops the first phase of this research, which involves reviewing the regulatory, 
practical and epistemic barriers and opportunities to eco-effective design of medical devices and their 
relevance to the research questions identified. Each set of barriers and opportunities has been detailed in a 
separate section, provided with an analysis of the findings and their relevance to the research questions.   
The fifth chapter develops the second phase, which involves mapping the material flows in the context of 
medical device lifecycles. The mapping process has been explained, elaborating on the structure and 
elements of the map and the various relationships it entails. This has been followed with the identification 
of barriers and opportunities to cradle-to-cradle design in the context of medical devices.  
The sixth chapter proposes a set of design principles for eco-effective design of medical devices, developed 
through the analysis and findings of phases one and two. These principles are then applied to develop a 
framework to integrate eco-effective design with the medical device design process. The framework is 
supported by an example illustrating the use of the framework. The framework and its underlying principles 
are evaluated using face-validation interviews with field experts, and the results of the interviews are 
tabulated. The interviews have been used to validate the principles of eco-effective design for medical 
devices, and also identify the limitations to the use of the framework. 
The seventh chapter discusses the findings of this project with a cumulation of the results identified in the 
two phases. The first section provides the contribution to knowledge through the answers to the two research 
questions. The chapter further identifies the limitations within which this research project was conducted 
and the scope for future work in this area.  
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The eighth chapter closes this study with a conclusion section, summarising the research project, its 
contributions to knowledge and the overall understanding developed through this research. 
The appendices at the end provide details on the interviews conducted, including information of the 
interviewees, transcripts, permissions and supporting documents. The references have been categorised 
chapter-wise for further reading. 
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2. Literature Review 
In this chapter we elaborate on two reviews which form the basis for the research and analysis conducted 
in this study. The first review focuses on the medical device design process and how it fails to account for 
environmental impact factors. The second review focuses on ecodesign and its role in providing approaches 
to integrate environmental impact factors in the design process. 
2.1 Medical Device Design 
The process of the design and development of a medical device is often long, complicated and meticulous 
work. It involves the identification of needs of multiple stakeholders, the expertise of people with various 
skillsets, and the approval of a number of regulatory bodies before the product can successfully reach the 
clinician and be used for a patient. In their proposal of eco-effective design, Frei and Züst (1997) evidence 
that most of the environmental impact of a product is determined by the decisions made at the early stages 
of the design process, specifically those made before the definition of the list of requirements. In this study, 
we are concerned with the environmental impact of medical devices and how eco-effective design strategies 
can be integrated in the early stages of the design process. This section elaborates on the early stages of the 
design process for medical devices, and explores the nuances which have been kept in mind while 
identifying opportunities for integrating eco-effective design strategies. 
There is no single design process for medical devices that is adhered to all over the world. Over the years, 
academics and professionals have developed multiple models and frameworks to communicate the complex 
process of medical device development from identifying needs to post-market evaluation of the device. In 
table 1, we identify five such models and highlight the factors that have been considered in the early stages 
of the design and development process.  
 
Table 1. Medical device design processes (early stages) 
S. No. Source Design Process (Early Stages) 
1. Santos et al., 2012 Idea Creation → Concept Development → Design 
2. Alexander et al., 2001 Device User Needs → Device Design Input → Device Design 
3. Ocampo and Kaminski, 
2019 
Strategic and Project Planning → Feasibility Study → System Design 
4. Pietsch et al., 2009 Initiation/ Opportunity and Risk Analysis → Formulation/ Concept and Feasibility 
Phase → Design and Development/ Verification and Validation Phase 
5. Medina et al., 2013 Product Definition Process → Design Process → Risk Management Process 
The table above provides a simplified understanding to the complex process, and how it has been 
approached by various academics. It is also important to note that the process is not necessarily as linear as 
  
19 
it has been shown in table 1 and can undergo multiple iterative cycles before a product is developed. The 
main take away from the table above is that the early stages of a project broadly consist of an input phase, 
which may involve needs identification, user requirements, device requirements and validation 
requirements, and an output phase which involves project planning, ideation, concept development, and 
concept selection. Table 2 provides a list of requirements that are factored in the input phase, as proposed 
by academics for four of the design processes mentioned in table 1. 
Table 2. Project requirements at the early stages of the device development process 
S. No. Source Project requirements at early stages of the process 
1. Santos et al., 2012 Market opportunity, technological feasibility, financial viability, 
commercialization space, reimbursement strategy, business analysis, 
customer needs, predicate device analysis, “headroom” for improvement 
2. Ocampo and Kaminski, 2019 Product portfolio, product scope, project scope, market analysis, user 
needs, clinical and regulatory requirements, economic and financial 
requirements, user risks 
3. Pietsch et al., 2009 Financial review, market analysis, competitive assessment, risk 
assessment, legal/ IP assessment, regulatory and clinical path, 
reimbursement path, core team, project plan, customer input,  
4. Medina et al., 2013 Needs identification, competencies analysis, customer analysis, market 
analysis, technology analysis, competitive analysis, regulatory analysis, 
legal/IP analysis, reimbursement strategy, financial analysis, performance 
characteristics, product characteristics 
From table 2, we can see that the requirements for developing a medical device are similar for each of the 
proposed design processes. Yet, a common absence from the list is any environmental impact factor. A 
study by Moultrie et al. (2015) involved interviews with 35 medical device designers, exploring the barriers 
to environmentally conscious design of medical devices. They found that designers perceived cost, client 
demands, regulations and potential risks to be important barriers to environmentally conscious design of 
medical devices. Thus, unless actively within the list of existing requirements, the focus on ecodesign of 
medical devices is often limited. 
In this study, we explore the barriers and opportunities to eco-effective design strategies for medical 
devices, and one aspect of our study is to see how the existing requirements, such as regulations and device 
design practice encourage or discourage eco-effective design. In section 2.2 we identify specific 
characteristics of eco-effective design that must be satisfied by a product for it to generate a positive 
environmental impact. In section 6.1, we identify the principles of eco-effective design for medical devices 
to develop a framework that integrates these characteristics as requirements in the design process. These 
principles work as the foundations for developing requirements to factor environmental impacts at the early 
stages of medical device design.
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2.2 Ecodesign 
This project explores the application of ecodesign for medical devices in an attempt to understand the 
barriers and opportunities for eco-effective design in this industry. While many attempts at eco-effective 
design can be found in academic literature, there is very little research available for eco-effective design 
strategies for medical devices, despite the promising results eco-effective measures have brought to the 
automotive, electronics and consumer appliances industries among others (Kumar and Putnam, 2008; 
Kumar et al., 2017).  
In this section we elaborate on ecodesign and the concepts of eco-efficiency and eco-effectiveness based 
on current academic literature. We also explore the notion of product life extension and the concept of 
cradle-to-cradle as has been used to explore eco-effective design strategies in this project. These concepts 
form the theoretical base that has been used for identifying the barriers and opportunities for eco-effective 
design for medical devices. 
The concept of ecodesign was first defined by Sim Van der Ryn (2007, p. 33) in 1996 as ““any form of 
design that minimizes environmentally destructive impacts by integrating itself with living processes.” This 
integration implies that the design respects species diversity, minimizes resource depletion, preserves 
nutrient and water cycles, maintains habitat quality, and attends to all the other preconditions of human and 
ecosystem health.” In the 20 years hence, the concept has been expanded and applied to a variety of methods 
and tools including lifecycle assessment (LCA), computer-aided design (CAD)-integrated, diagram-based, 
checklists, guidelines and design for X methods (Rossi et al., 2016). 
The term effectiveness implies the measure of goal achievement, and can be contrasted with the term 
efficiency, which refers to the resources used to achieve a goal. The concepts of efficiency and effectiveness 
were applied to ecodesign by Frei and Züst (1997), defining eco-effective design as the integration of 
environmental considerations at the early stages of the design process, namely the product planning and 
task clarification stages. According to them, beyond the task clarification stage, only eco-efficiency of the 
product can be influenced. This was further validated by Bhamra et al. (1999) in their survey of 30 
electronics companies on how they were implementing ecodesign in their products.   
As cited by Ehrenfeld (2005, p. 6), “The WBCSD (World Business Council for Sustainable Development) 
describes eco-efficiency as “being achieved by the delivery of competitively priced goods and services that 
satisfy human needs and bring quality of life, while progressively reducing ecological impacts and resource 
intensity throughout the life cycle, to a level at least in line with the Earth’s estimated carrying capacity.”” 
This definition highlights the main difference between eco-effectiveness and eco-efficiency. While eco-
effectiveness is a proactive approach to establishing limits to environmental impact through the elimination 
of toxicants and the integration of environmental goals at the early stages of the design process, eco-
efficiency is less goal oriented and relies on a progressive reduction in environmental impact and resource 
consumption.  
  
21 
Eco-efficiency is, in principle, some measure of economic value against the environmental impact 
generated (Ehrenfeld, 2005). Thus, a system is more eco-efficient if either the economic value rises for a 
set environmental impact, or the environmental impact is reduced for a set economic value. The 
International Standard Organization (ISO) suggests that the best method of determining the environmental 
impact is through an LCA. An LCA can provide an analysis of a range of environmental impacts including 
eco-toxicity, eutrophication, and carbon dioxide emissions for the entire lifecycle of a product from the 
materials extraction stage till the end-of-life stage (Hauschild, 2015). While the LCA is considered as the 
industry standard for analysing eco-efficiency, there are limitations to its application, such as the 
authenticity and validity of the data used for the analyses, and the tendency for companies to reduce the 
impacts to a single variable such as carbon dioxide emissions, which over-simplifies the problem to a 
detrimental effect (Hauschild, 2015). 
The application of eco-efficiency can be achieved through design strategies that dematerialize the product 
(reducing environmental impact), extend the useful life of the product, and provide material recovery 
options like recycling for products that no longer suit their intended purpose (increasing economic value). 
The concepts of product-life extension such as reuse, repair and reconditioning were suggested as useful 
strategies to gradually transition to a sustainable society as early as 1982 (Stahel, 1982). Product-life 
extension reduces the reliance on virgin materials (environmental sustainability), provides employment 
opportunities (social sustainability) as well as opportunities for economic growth through consumption and 
service models for optimum use of the resources in hand (economic sustainability). These concepts have 
been further detailed to specific strategies which can be incorporated in the design of products (Bakker et 
al., 2014).  
In essence, eco-efficiency focuses on reducing negative environmental impacts, while eco-effectiveness 
relies on increasing a positive impact on the environment. But in a limited resource setting such as that of 
our planet, a progressive reduction in environmental damage with no absolute goals is not feasible, and 
often tends to shift the focus from radical change which is needed, to incremental change which is easier to 
implement, but less effective (Ehrenfeld, 2005). The main concern with eco-efficiency is that it is 
detrimental to reducing environmental impacts if it leads to higher consumption, also known as the Jevons 
Paradox (Abukhader, 2007). Thus, while eco-efficiency provides feasible short-term goals to progressively 
reduce environmental impacts, it fails to address the long-term vision in meeting the needs of a limited 
resource setting and ensuring sustainable forms of production and consumption for all. Here, eco-
effectiveness plays a more important role (Hauschild, 2015).  
To integrate eco-effective design with the early stages of the design process, Frei and Züst (1997) propose 
an environmental learning cycle as a method of achieving continuous improvement in environmental 
performance (Figure 1). This cycle helps decision-makers understand the relationship between the defined 
product functions and the resulting material and energy flows of the proposed solution and their impact on 
the environment. This cycle of definition, modelling, assessment and analysis is the basis for eco-effective 
product design, providing a comprehensive understanding of the environmental aspects of a product’s 
functions (Frei and Züst, 1997). 
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Figure 1. Environmental learning cycle (Frei and Züst, 1997) 
Within the gamut of eco-effective design philosophies is one called cradle-to-cradle which considers 
materials in use as nutrients flowing through a metabolic system (Braungart et al., 2007). While the take-
make-use-dispose system would constitute a linear flow of materials from cradle-to-grave, this philosophy 
strives to achieve eco-effectiveness by ensuring a continuous flow of materials from cradle-to-cradle to 
maintain or increase the value of the resources used. Inspired by the “interdependence and regenerative 
productivity of the natural systems”, Braungart et al. (2007, p. 1342) suggest that all nutrients in a cradle-
to-cradle system flow through either a biological metabolism or a technical metabolism. Biological 
nutrients naturally degrade or are consumed and contribute to the growth of living ecosystems, while 
technical nutrients are recovered and reused over multiple cycles within industrial ecosystems. They 
propose a five-point framework for transitioning from eco-efficient to eco-effective product design, which 
involves eliminating all known toxicants from the material flows, identifying alternatives to the eliminated 
materials, defining how they fit within biological or technical metabolisms, and developing appropriate 
service and consumption models to maximize their value within these metabolisms. While this framework 
may help design products for a cradle-to-cradle lifecycle, the actual eco-effectiveness of the product 
depends on the compliance and initiative of the stakeholders beyond the design phase, which includes the 
manufacturer, the user, and the product-life extension and recycling systems in place (Bjørn and Hauschild, 
2012). 
Based on the definitions provided by Frei and Züst (1997) and Braungart et al. (2007) we have summarised 
the characteristics of eco-effectiveness into three points. 
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1. Elimination of known toxicants - In order to generate positive environmental impact, it is important 
to eliminate the substances that contribute to a negative environmental impact. The cradle-to-cradle 
design framework identifies this as the first step towards eco-effective design (Braungart et al., 
2007). The environmental learning cycle also focuses on environmental impact assessment as the 
first checkpoint in identifying and mitigating negative environmental impacts (Frei and Züst, 1997). 
Thus, the elimination of known toxicants forms an integral part of the process of eco-effective 
design. 
2. Closed loop material flows - To ensure that there is no waste generated, and all resources are treated 
as renewable, the material flows must be looped, and any waste generated in one system is treated 
as a resource for another system. This characteristic is echoed in Stahel’s concept of the 
performance economy (Stahel, 1982), and in the cradle-to-cradle design framework in the form of 
technical and biological metabolisms (Braungart et al., 2007). Furthermore, the creation of material 
flow loops reduces the reliance on virgin materials, which necessarily requires high energy 
investments in exploration, excavation and extraction. 
3. Ensuring the maintenance or upgrade of resource quality - By ensuring the absence of ecotoxicants, 
the continuous flow loops of materials, and the absence of waste, it is necessary that the resources 
in use are at least maintained at their original quality (to prevent waste), and it is preferred that the 
products and resources are upgraded to generate more value. This ensures the generation of a 
positive environmental impact with the same resources, thus fulfilling the requirements of eco-
effectiveness.  
These characteristics can be further seen in reference to the environmental learning cycle and the five-point 
cradle-to-cradle design framework, as depicted in table 3. 
Table 3. Characteristics of eco-effective design 
S. No.  Conceptual frameworks of eco-effective design Characteristics of Eco-Effective Design 
 
Environmental Learning Cycle (Frei and Züst, 1997) 
 
1. Definition of the function 
2. Approach to solution 
3. Material and energy flows 
4. Environmental impact 
Elimination of known toxicants 
5. Impact assessment 
6. Causal analysis 
 
Cradle-to-cradle design (Braungart et al., 2007) 
1. Free of... 
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2. Personal preferences 
Closed loop material flows 
Ensuring the maintenance or upgrade of 
resource quality 
3. The passive positive list 
4. The active positive list 
5. Reinvention 
These characteristics are crucial for the eco-effective design of any product. But the application of these 
characteristics depends on multiple factors and varies from industry to industry. To understand how these 
characteristics of eco-effectiveness can be implemented in a specific industry, it is important to know what 
are the barriers and opportunities to the eco-effective design of the products being created.Eco-effective 
measures have been adopted by a number of industries in various ways. Kumar and Putnam (2008) studied 
the forces that influence the closing of supply chain loops in the automotive, consumer goods and 
electronics industries. In the automotive and electronics industries, there is a growing regulatory push for 
the reuse and recovery of materials. Furthermore, the price of virgin materials such as copper, steel and 
aluminium is rising due to increasing demands and limited supply. Thus, these industries, along with the 
consumer appliance industries are relying more on recycled material sources. A barrier to the disassembly 
and recycling of old vehicles and consumer appliances is the presence of hazardous substances such as lead, 
mercury and chlorofluorocarbons. Thus, these industries are also shifting to a design approach that 
integrates reuse and recycling, and eliminates the use of hazardous substances. In the appliance industry, 
there is a further demand for greener products from the consumers, and so designers are factoring reverse 
logistics in the design of products to facilitate product-life extension and material recovery or safe disposal 
strategies (Kumar and Putnam, 2008). 
Fernando and Evans (2016) studied two automotive companies, two textiles manufacturers and a sugar 
manufacturer to understand the competencies required to transition from eco-efficiency to eco-
effectiveness. They found that a focus on efficiency helps companies move towards a zero-waste system. 
When these companies approach maturity in eco-efficiency, they start internalizing zero-waste processes 
or collaborating with facilities that can help improve their sustainability factor. Inadvertently, this wider 
scope of process control helps companies focus on the system as a whole and change processes which can 
help them achieve effective solutions to sustainability (Fernando and Evans, 2016). This transition to eco-
effective measures is even witnessed in energy companies. Backer and Clark (2008) studied the formation 
of Shell Renewables and found that, although the decision to explore renewable energy sources was a 
response to dwindling oil reserves, this eco-effective decision not only helped the company economically, 
but also provided a new image of an environmentally conscious company. Neither of these benefits was 
foreseen when the company established Shell Renewables, and Backer and Clark (2008) also note that 
successful business cases for eco-effective decisions are not always predictable, but the first-mover 
advantage may have contributed to this success. 
Although an encouraging and radical alternative to the practice of eco-efficiency, cradle-to-cradle and eco-
effective design have their own fair share of criticism too. The problem with integrating eco-effectiveness 
at the early stages of the design process is the lack of sufficient information at this stage to guide the design, 
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even though these decisions play an important role in defining the product (Frei and Züst, 1997; Bhamra et 
al., 1999). This challenge can be overcome by analysing a reference product and determining the 
appropriate eco-effective decisions for the new product (Frei, 1998). Bjørn and Hauschild (2012) argue that 
the limited focus on energy systems, the reliance on wider systemic logistics to ensure cyclic flows of 
nutrients makes cradle-to-cradle and eco-effective design a weak force to implement in the growing 
problems of environmental concerns. Furthermore, they argue that the concept of perfect resource cycles is 
still a utopian idea as even in nature there are no perfect nutrient flows, and the improper replication of 
these flows can even be detrimental to the environment. It is also naive to assume that these perfect nutrient 
metabolisms can be a solution to resource scarcity because as long as more development projects take place, 
there will always be a need for new resources to tap into. Toxopeus et al. (2015) tested the validity of the 
C2C certification program by applying it to a toilet paper packaging project. They found that the restriction 
on the process due to non-disclosure agreements, the lack of transparency on evaluation criteria and the 
limited purview of the certification on material health (and not the energy factors) resulted in more 
optimization of the product, rather than eco-effectiveness. 
Due to the inherent shortcomings of the short-term eco-efficiency approach and the long-term eco-effective 
approach, researchers suggest that a combination of the two may help overcome the limitations of each 
strategy. While cradle-to-cradle design may be very effective in low-resource settings, LCA can provide an 
understanding of the limited resources and help optimize the allocation of these resources (Bjørn and 
Hauschild, 2012). Niero et al. (2017) used a combination of lifecycle assessment and the C2C certification 
program to develop a list of actions required for an efficient and effective upcycling strategy for, in their 
case, aluminium cans. The C2C criteria was used to develop effective material health strategies, while LCA 
was used to evaluate these strategies and suggest improvements for optimization. Bakker et al. (2009) 
studied two master’s thesis design projects which applied the C2C concept and identified that the C2C 
framework worked well with the initial stages of design and allowed designers to demonstrate how new 
products and business models can help a company shift to a C2C business. They also suggest that LCA can 
be used to prioritize certain environmental requirements and monitor the energy consumption of the product 
within an overall framework of C2C. 
Thus, it is evidenced that the approach to ecodesign should capture the vision of eco-effectiveness with the 
practicality of eco-efficiency. This study builds on these concepts of ecodesign and identifies their 
application in the medical device industry. The following chapters delve into the regulatory feasibility of 
ecodesign within the medical device industry, and the existing progress made in ecodesign strategies in this 
field. We find that though there are some examples of eco-efficiency models and examples applied to 
medical devices, the eco-effective strategies have not been explored so far. This study identifies the barriers 
and opportunities for eco-effective design strategies, and develops the principles of eco-effective design for 
medical devices.  
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3. Methodology 
Medical devices have a significant environmental impact, as has been evidenced in section 1.2. 
Furthermore, section 1.3 elaborates on how the design of these devices contributes notably to the various 
downstream decisions which are responsible for the resultant environmental impact. In our review of 
medical device design processes, we found a lack of design requirements that directly focus on 
environmental impact of the devices. Although eco-effective design strategies have been adopted in other 
industries, the same has not been evidenced in the design of medical devices.  
To understand the reasons for a lack of research on eco-effective design for medical devices, this study 
aims to address the following two research questions: 
1. What are the barriers and opportunities for eco-effective design of medical devices? 
2. How can these eco-effective strategies be integrated in the design process? 
The identification of barriers and opportunities to eco-effective design of medical devices has been 
conducted through two phases as described below. 
The first phase involves literature reviews identifying the regulatory, practical and epistemic barriers and 
opportunities to eco-effective design of medical devices. Hauschild (2015) argues that while bottom-up 
approaches like cradle-to-cradle design help develop a vision for new product and business strategies to 
achieve sustainable solutions, a top-down approach is equally important to determine the limits within 
which new solutions must operate. Murphy (2012) also reiterates the need for both top-down and bottom-
up solutions to resolve the wicked problems of sustainability and its multiple facets. The analysis of the 
regulatory framework guiding medical device lifecycles helps identify the scope for exploring eco-effective 
design for medical devices within the legal framework existing today. The opportunities identified were 
further validated with a review of literature exploring existing practices in this field. This review helped 
identify the practical barriers and opportunities that have been explored by companies and have been 
documented in academic literature. Eco-effective design is still a relatively new concept, and the knowledge 
base continues to grow both in academic literature, and the experimentation in various industries. The third 
review helps identify the epistemic barriers and opportunities to eco-effective design of medical devices, 
by understanding the existing knowledge in ecodesign methods for medical devices. The opportunities and 
barriers were then compiled, and analysed to identify important factors that affect eco-effective design of 
medical devices. The reviews were conducted by identifying journal and conference papers through specific 
keyword searches on Google Scholar. The reason more specific libraries were not targeted is the variety of 
fields and disciplines that this research has been developed on, including but not limited to design, 
engineering, management, industrial ecology, medicine, healthcare, sustainability, and systems theory. 
The second phase of this research was conducted using mapping of material flows as a method for 
identifying barriers and opportunities for cradle-to-cradle design of medical devices. In this phase, the 
material flows have been mapped and layered with the information on the regulations and stakeholders 
associated with the processes involved in medical device lifecycles. The maps were constructed with 
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information from existing LCA studies of medical devices and consumer products, as well as the regulations 
studied in Phase 1. Mapping of complex systems as a method for developing new perspectives and new 
solution spaces is an established practice in the field of systems-oriented design (Sevaldson, 2013). 
Sevaldson (2013) argues that designers are trained to engage with complexity through creative 
visualizations, providing new perspectives to identify solutions in systems with multi-layered information 
hierarchies. The mapping of material flows is not only an important part of the environmental learning 
cycle, proposed by Frei and Züst (1997) as a method for integrating eco-effective design with the early 
stages of the design process, but also a method for exploring the technical and biological nutrient 
metabolisms (Braungart et al., 2007) within the boundaries of the regulatory framework for medical 
devices. This process of exploring opportunities and barriers through mapping is particularly relevant to 
this research due to the complex regulatory, stakeholder and process relationships in the medical device 
industry which can be explored better through visualizations as have been explored by Sevaldson (2013) in 
multiple projects.  
The research through phases 1 and 2 provides an answer to the first research question on barriers and 
opportunities to eco-effective design of medical devices. To understand how these opportunities can be 
leveraged and the barriers mitigated, we proposed principles of eco-effective design for medical devices. 
The need for these principles is because there is a low uptake of ecodesign tools and methods by companies 
due to the generic nature of the available frameworks, and a need for more industry-tailored approaches, as 
reviewed by Rossi et al. (2016). While eco-efficiency approaches for medical device design do exist, we 
have already discussed the need for eco-effective approaches and the need to develop long-term strategies 
to manage environmental impact and resource utilization (Refer to section 1.3 and 2.2). 
The principles, based on the findings from phases 1 and 2, were used to propose one instance of a framework 
for identifying and applying eco-effective design strategies on medical devices. The framework was 
elaborated with an example of the redesign of an endotracheal tube and suggested what the ideal eco-
effective cradle-to-cradle scenario in a medical device could resemble. The framework was further tested 
through face-validation interviews, and the feedback from the experts helped validate the underlying 
principles of the framework and their relevance to integrating eco-effective measures in the design of 
medical devices The semi-structured interviews use a naturalistic, qualitative approach to evaluate the 
framework and its underlying principles (Blessing and Chakrabarti, 1999; Patton, 1990). 
The framework serves as a probe to validate the principles of eco-effective design that have been developed 
through this study. The use of a solution-oriented probe to develop a better understanding of the problem 
is a method rooted in the resolution of wicked problems (Rittel and Webber, 1973) as well as the exploration 
of complex systems in systems-oriented design (Sevaldson, 2013). In their seminal work on wicked 
problems, Rittel and Webber (1973) describe how understanding the problem is naturally accompanied 
with problem resolution, because the solution-oriented approach anchors the perspective and helps develop 
new connections between elements of a system as well as identify new elements of the system. The delivery 
of safe and effective healthcare as well as the need to achieve sustainable forms of production and 
consumption are well documented as wicked problems, and thus have no unique solutions to mitigate them 
(Periyakoil, 2007; Murphy, 2012). These problems must be resolved through dialogue and compromise to 
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arrive at an acceptable consensus. For this research, we anchor the perspective to the designers’ agency for 
developing eco-effective medical devices.  
These two phases of the research form the methods used to understand how designers can work towards 
eco-effective design of medical devices within the regulatory framework guiding the lifecycle of medical 
devices.   
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4. Phase 1 - Barriers and Opportunities for Eco-Effective Design 
of Medical Devices 
The first phase assesses the regulatory, practical and epistemic barriers and opportunities to eco-effective 
design of medical devices through three reviews. We use a critical analysis of the regulatory framework to 
identify barriers and opportunities to eco-effective design for medical devices and define the system 
boundaries within which this research operates. We then identify literature which supports the practice of 
ecodesign for medical devices, and how this practice works within the regulatory framework. The third 
review explores the current epistemic base in published literature guiding ecodesign, more specifically 
looking at its application in medical devices. The results of the reviews are summarised and tabulated, 
indicating the evidence relevant to the research questions. Through this phase, we review the existing 
knowledge base on eco-effective design for medical devices. 
4.1 Review 1 - Regulatory Barriers and Opportunities 
Within the regulatory framework for medical device lifecycles, there are different stakeholders affected by 
different policies at different governance levels. For example, in England, the manufacture and use of a 
medical device is guided by the European Union through the EU Medical Device Regulations (MDR) 
(European Commission, 2017), whereas the management and disposal of these devices is guided by the 
Department of Health and Social Care (DHSC) through various policies (DHSC, 2014). Furthermore, the 
management and disposal strategies vary between the four countries of England, Wales, Scotland and 
Northern Ireland, depending upon the infrastructure available, and the best practice strategies developed 
(DHSC, 2013b). Thus the hierarchies of policies change at different stages of the lifecycle of a medical 
device, and so does the stakeholder associated with a medical device. To reduce the variability in 
regulations, we further define the context, and limit our research to England, to develop a more specific 
understanding of the lifecycles of medical devices within a more defined system boundary. Figure 2 
illustrates the regulations applying in England, and the hierarchies that they adhere to. 
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Figure 2. Regulations and policy hierarchy structure for medical device lifecycles in England 
4.1.1 Critical Analysis of Regulations 
In order to understand the problem further, we critically analysed the policies and identified the regulatory 
barriers and opportunities for the eco-effective design of medical devices. Thus, we identified barriers and 
opportunities to the characteristics of eco-effectiveness as mentioned in section 2.2. 
1. Elimination of known toxicants 
2. Closed loop material flows 
3. Ensuring the maintenance or upgrade of resource quality 
Five main documents were identified which direct the lifecycle of a medical device within the context of 
England, and these were critically analysed, as provided in Table 1. The MDR provides a complete 
understanding of the regulations that a device must conform to in order to be deemed suitable for market 
release and use in clinical settings (European Commission, 2017). The focus of the MDR is to ensure that 
there is accountability and transparency in the process of developing a medical device, and there is adequate 
attention given to the health and safety of the patients as well as the clinical staff handling the device. The 
Health Technical Memoranda (HTM) are best practice guidance documents created by the Department of 
Health and Social Care (2014) for healthcare providers and other stakeholders involved in the processes of 
care. In this research, we cover the memoranda specific to the management, use, decontamination and 
disposal of medical devices (namely HTM 01-01, 01-05, 01-06, 07-01). Table 4 provides the main barriers 
and opportunities identified for eco-effective design of medical devices in each policy studied. Based on 
the characteristics of eco-effectiveness identified earlier, we have highlighted the regulatory barriers and 
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opportunities on a colour code provided in table 4 to suggest how they affect eco-effectiveness. We then 
discuss the implications of these barriers and opportunities on each of the eco-effectiveness characteristics.  
Table 4. Regulatory barriers and opportunities to eco-effective medical devices 
(ecotoxicity, closing material loops, maintenance/upgrade of resource quality) 
S. 
No. 
Medical Device 
Lifecycle Stage 
Regulation/Policy Barriers to 
eco-effectiveness 
Opportunities for 
eco-effectiveness 
1. Manufacture and 
Use 
Regulation (EU) 
2017/745 
1. Annex 1, Chapter 2, point 10.1: 
Flammability and toxicity of 
materials used considered only for 
production and use phase, not 
disposal phase. 
1. Annex VIII, Chapter 1, point 2.3: 
Lower regulatory conformity for 
transient reusable surgical devices 
(class I) as compared to other surgical 
devices (class IIa) 
2. Article 17: Reprocessing legal while 
within the policies of individual 
member states 
3. Article 23, 24: Free market for 
remanufactured components, devices. 
4. Article 54: No reapplying for 
regulatory conformity on minor 
upgrades on device through 
remanufacture. 
2.  Safe management 
& 
decontamination 
HTM 01-01  1. Outsourcing, point 4.23: 
Organizations free to resort purely 
to single-use devices in case of no 
decontamination facilities. 
1. Guidance for commissioners, 
regulators and providers, point 3.2, 
4.8: Providers may reprocess their 
devices on or off-site, while following 
necessary conformity measures. 
3.  Decontamination 
of primary care 
dental practices 
HTM 01-05 1. Point 2.18: Endodontic files and 
reamers designated as reusable 
must be treated as single-use. 
2.Point 6.14: Protective equipment 
includes disposable clinical 
gloves, household gloves, plastic 
disposable aprons, facemasks, eye 
protection, and footwear.  
3. Points 6.61, 6.65, 6.67: 
Disposable cloths for the patient 
treatment area, disposable covers 
for devices 
 
4.  Management of 
Flexible 
Endoscopes 
HTM 01-06 1. Point 1.13, 2.7a, 5.17a,  5.17f, 
5.20: Mandatory to use single 
use liners, brushes, sponges, 
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channel port valves, other 
endoscope accessories, cleaning 
aides for decontamination 
processes 
5.  Management of 
Healthcare Waste 
HTM 07-01 1. Point 4.125, 4.24: Home 
healthcare waste classified as 
healthcare waste, but treated with 
municipal waste. 
3. EWC Codes, Table 3: Last stage 
for non-clinical, non-infectious 
waste must be landfilling. 
4. Figure 10: Only 1 of 8 
categories of waste must be 
recovered, while another proposes 
segregation of recyclables, all 
other waste streams are 
incinerated/landfilled 
5. Figure 11: Only 3 out of 20 
waste streams must be recovered, 
while another 3 can be recovered. 
Rest are incinerated/landfilled 
6. Criterion B, point 9.9: All 
anatomical waste must be 
incinerated 
1. Assessment of offensive/hygiene 
properties: Offensive waste need not 
be treated as infectious waste and can 
be treated for municipal waste 
recovery. 
2. Specific waste types, points 4.149, 
4.150: Hazardous substances in 
implants must be recovered and 
treated appropriately. 
4.1.2 Analysis 
1. Implications for eliminating ecotoxicity 
There were two concerns identified that hinder the elimination of ecotoxicants from the medical device 
lifecycles. The first is that the MDR for medical devices does not advise on the toxicity impacts of devices 
beyond their production and use stage (EU, 2017). Thus, the regulations do not guide the product 
development for scenarios beyond the use phase, despite instructing the manufacturers to inform users of 
the decontamination and disposal strategies to adopt (EU, 2017) (Figure 3). While the Waste Electrical and 
Electronic Equipment Directive (WEEE) (EU, 2012) does address the disposal of electronics, non-
electronics which may be potentially hazardous are not addressed. 
  
33 
 
Figure 3. Regulations for toxicity of substances used or produced at various stages of the lifecycle of a 
medical device 
The second concern is regarding the management of home healthcare waste. Although medical devices may 
be used in homes, and there has been a rise in providing healthcare at home to reduce the pressure on 
hospitals, the management of the waste generated in home healthcare is treated as municipal waste instead 
of as healthcare waste (DHSC, 2014) (Figure 4). Thus, potentially infectious and hazardous waste may also 
be landfilled along with municipal waste, potentially leading to the spread of communicable infections from 
this waste. As home healthcare waste goes into the domain of municipal waste and is not effectively dealt 
with by the DHSC, the implications of home healthcare waste are beyond the scope of this project. More 
research is required to assess the dangers of landfilling home healthcare waste. 
 
Figure 4. Regulations on management and disposal of home healthcare waste 
2. Implications for closed loop material flows 
The opportunities for closing loops for material flows can be summarised in two points. The first is the 
opportunities identified for product-life extension of medical devices, which includes reuse, repair, 
reprocessing, and remanufacture as depicted in figure 5. Due to the risks involved in the potential 
reprocessing and remanufacture of medical devices, the MHRA (2016; 2018) has provided appropriate 
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guidance and specified the potential implications in case of negligence or malpractice in these processes. 
The second point is regarding the opportunities for material recovery, which are partly directed by the 
WEEE for all products containing electrical and electronic components and partly by the DHSC (EU, 2012). 
The WEEE indicates that all products containing electrical and electronic components (active devices, in 
the case of medical devices (EU, 2017)) must be recovered and cannot be disposed of due to the possibility 
of leaching of heavy metals into the environment and the explosive nature of batteries under high 
temperature. Secondly, the DHSC has advised that offensive waste such as incontinence pads and sanitary 
napkins may be treated as municipal waste, thus opening the opportunity for recovery through recycling 
(DHSC, 2014). 
 
Figure 5. Product-life extension strategies for medical devices 
There were multiple barriers to achieving eco-effectiveness identified in the regulations which can be 
summarised in three points. Firstly, hospitals with no access to decontamination facilities are free to use 
single-use devices for all purposes, thus eliminating any scope for closing the material flow loops (Figure 
6). Secondly, there is an active push (and in some cases, mandatorily imposed) to dispose of protective 
equipment, device cleaning equipment and general covers, liners and even some devices after a single use, 
even if designed for multiple uses (DHSC, 2013; 2016). This policy has been imposed due to the increasing 
risks of transmitting the Creutzfeldt-Jakob Disease through prions from reused devices and a general fear 
of reinfection, despite there being limited research to indicate the increased risk of reinfection from 
reprocessed devices as compared to new devices (DHSC, 2013; 2016) (elaborated further in section 4.2.1). 
The third limitation is the overall structure of the management strategies available for the various types of 
waste produced at hospitals. While most of the waste produced at healthcare providers must either be 
landfilled or incinerated, there are very few waste recovery strategies available. These recovery strategies 
are heavily dependent on the efficient segregation of the waste to minimize the toxic and hazardous waste. 
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Figure 6. Regulatory barriers to looping material flows 
3. Implications for maintenance/upgrade of resource quality 
We found one opportunity each for maintaining or upgrading resource quality. The MDR (EU, 2017) 
classifies reusable transient devices as Class I as opposed to single-use transient devices as Class IIa, IIb or 
even III. Thus, the reusable version has lower conformity requirements and thus requires less investment 
for regulatory assessment as compared to a single-use device with the same functions. Secondly, in case of 
minor upgrades to a device, the regulations do not impose a need to re-certify a device, providing the 
opportunity to upgrade devices within a certain limit without needing a new assessment for the new product, 
making it easier to improve the product, rather than produce and certify new ones each time. 
Next steps 
Although we have identified multiple barriers to achieving eco-effectiveness in our review of the regulatory 
framework, the proposal of alternative policies to mitigate these barriers is beyond the scope of this project. 
We focus on the opportunities identified for closing loops for material flows, and how can these 
opportunities be leveraged for eco-effective medical device design. The next section focuses on the practical 
implementation of closing loops for material flows for medical devices, and the barriers and opportunities 
therein.
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4.2 Review 2 - Practical barriers and opportunities 
Through our review of the regulatory framework on medical device lifecycles, we identified that certain 
product-life extension and material recovery strategies may be legally used to maintain or upgrade medical 
devices in England. These strategies help to promote eco-effective lifecycles of the devices through looping 
of material flows and maintaining or upgrading the value of the resources used. To facilitate the eco-
effective design strategies, they must be integrated in the early stages of the design process (Frei and Züst, 
1997). Our second review focuses on identifying practical barriers and opportunities to eco-effective design 
of medical devices. In their review, Kane et al. (2018) found practical implementation of some of the 
product-life extension and material recovery strategies identified in the previous review across the globe 
and identified practical barriers to product-life extension and material recovery in the medical device 
industry. We identified further barriers and opportunities to these product-life extension and material 
recovery strategies in existing practices through literature, as have been detailed below in Table 5. The key 
words used for identifying the literature include, “reuse medical device”, “repair medical device”, 
“reprocess medical device”, “remanufacture medical device”, and “recycle medical device”. 
Table 5. Opportunities and barriers to product life extension and material recovery strategies 
S. 
No. 
Product-life extension 
and material recovery 
strategy 
Opportunities Barriers 
1. Reuse 1. Reusable surgical devices are classified 
as class I and have lower regulatory 
conformity requirements as compared to 
single-use devices which may be classified 
as class IIa, IIb, or III (EC, 2017) 
1. Multiple cases of reinfection, disease 
outbreak recorded (Shuman and 
Chenoweth, 2012) 
2. Some cases require additional time and 
processing requirements (Bouthors et al. 
2019) 
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2. Reprocessing 1. A cost-saving measure for manufacturers 
for high-cost medium complexity devices 
(Shuman and Chenoweth, 2012). 
2. Recognized and supported by the MDR 
(2017) and MHRA (2018). 
1. Some cases reported inadequate 
decontamination and subsequent 
reinfection (Rutala and Weber, 2016) 
2. Single-use devices and their 
reprocessing is a cost burden on 
healthcare providers (Chang et al., 2018) 
3. Remanufacture 1. Established market for the 
remanufacture and sale of technologically 
obsolete devices from developed countries 
to underdeveloped nations at a lower price 
(Markets and Markets, 2016). 
 2. Recognized by the MHRA (2016) with 
appropriate accountability guidelines. 
1. Lack of clear definitions on 
remanufacture in medical device 
regulatory policies (Eze et al. 2019) 
4. Recycling 1. Has the potential to reduce toxins like 
furans and dioxins being generated from 
waste incineration (Windfeld and Brooks, 
2015) 
1. Cost implications of infrastructure, and 
a need for staff to be educated on 
recyclable materials and appropriate 
segregation (Azouz et al. 2019) 
4.2.1 Analysis 
Based on the literature reviewed, we can identify a few factors that affect the decisions to extend the product 
life and the recovery of material in the medical device industry. The first factor is the risk of reinfection to 
patients. It has been found that one of the main barriers to product-life extension of medical devices through 
reuse, reprocessing or remanufacture is the risk of reinfection due to ineffective decontamination of the 
device. In fact, this risk of reinfection is one of the reasons that the industry shifted to more single-use 
devices, which in addition, did not require the manpower and costs for cleaning the devices before use 
(Chang et al. 2018). In the 1960s, manufacturers found it cheaper to develop plastic devices as compared 
with glass and metal, and hospitals found sterilization of plastics a huge investment, as this could not be 
achieved through the standard autoclave machines and required alternative systems (Greene, 1986). The 
single-use devices were further favourable to the manufacturers due to the lower regulatory requirements 
as compared to reusable devices. But hospitals were suffering due to the increased spending on single-use 
devices, and tight budgets to work with, so they started reprocessing these devices and using them. Soon, 
third party reprocessing firms emerged and original equipment manufacturers noticed this new market for 
reprocessing single-use devices, so they bought out these firms, and rebranded them as sustainability 
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initiatives. The reprocessed devices, although costing the manufacturer half of the production of the new 
device, were resold to hospitals at the rate of original devices, as they were certified to provide an equivalent 
performance and safety as compared to new devices, leading to higher profits for the manufacturers (Chang 
et al. 2018). 
Although the risk of transmission of pathogens has been considerably documented, it is not clear whether 
the risks from reusable devices are any more than those from reprocessed single-use devices. In the US, 
studies seem to indicate that the adverse events involving reprocessed devices were similar to those for new 
devices (Chang et al. 2018). Studies by the FDA showed there was no increased risk of infection due to the 
use of reprocessed devices. Their report reasserted that the adverse health events associated with the use of 
reprocessed devices were the same types and rates associated with non-reprocessed, new devices (GAO, 
2008). Within the ambit of reusable devices, Rutala and Weber (2016) and Alfa (2019) suggest that there 
is a need for stronger development of and adherence to protocol required to ensure proper decontamination 
of devices before use. Furthermore, the industry is still reliant on multiple reusable devices which are too 
expensive to be disposed of after a single use, and the number of successful reprocessing cases far outweigh 
the failures for the reusable model to be considered an outright risk for all patients (Chang et al. 2018). 
While multiple cases of reinfection have been reported over the years, it is not clear whether the errors are 
due to device design, decontamination technology, decontamination protocol, or medical negligence. In his 
review of surgical instrument decontamination failures, Southworth (2014) found that although not many 
cases were found, there is a low risk for cross-infections from reusable surgical instruments when the 
decontamination procedures are adhered to. His review further identified that almost half of the reported 
incidents studied suggest decontamination failures due to disinfection of surgical instruments instead of 
sterilization (Southworth, 2014). Even if the future of medical devices does rely on the single-use model as 
a best practice scenario from a safety perspective, decontamination will be key to recover the material and 
use safely in the same or other industries to enable eco-effective use of the materials. 
From the above discussion, we can infer that decontamination is an important process that can determine 
the reusability of a device. In fact, since the regulations enforce the incineration and subsequent landfilling 
of pathogenic material, decontamination further determines whether the materials used in the device will 
be disposed of in a cradle-to-grave approach, or have the potential for effective utilization for the same or 
other purposes in a cradle-to-cradle approach (DHSC, 2014). Figure 7 depicts the material flow cycles that 
can be developed if decontamination of devices is conducted successfully. As we have seen in the previous 
section and in figure 6, if devices are disposed of, there are not many recovery strategies available and that 
makes decontamination an important process for product life extension and material recovery of medical 
devices. 
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Figure 7. Role of decontamination in product-life extension and material recovery 
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The second important factor is the economics of product-life extension. While the developing world serves 
as an important market for remanufactured products, the reuse of medical devices tends to add costs of time 
and effort in the decontamination process as compared with single-use devices. In their study, Jensen et al. 
(2019) found that Philips had successfully integrated remanufacturing in their business strategies for high-
cost high complexity devices such as X-ray machines, and one of the reasons for this success is the built-in 
reliability through a whole systems approach, which ensures the product runs smoothly for long-periods of 
time. In their review, Damha et al. (2019) found 7 medical device case studies on end-of-life strategies for 
product service systems which indicated repair, reconditioning and facilitating sales as the most common 
strategies adopted. Yet, the reprocessing of certain single-use devices reduces the costs for supply of certain 
medical devices for the manufacturers, but raises the costs for hospitals in their inventory management and 
waste management as discussed above. The economics also varies from country to country, depending on 
the healthcare system in place. 
We can infer that medical devices require tailored strategies when it comes to integrating product-life 
extension and material recovery strategies, while providing economic feasibility, and these strategies will 
work differently in different healthcare systems, thus requiring a systems approach and developing context-
specific solutions. From a design perspective, it is clear that the product-life extension strategies identified 
above and their applications in medical devices have been documented and can be integrated in the design 
process for eco-effectiveness. Figure 8 depicts how various processes entailed in the lifecycle of a medical 
device are controlled by various stakeholders, which makes the development of value chains complex, and 
necessarily context-specific. More research is required to understand how successful business strategies 
can be developed for product-life extension strategies in the medical device industry for specific contexts. 
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Figure 8. Stakeholder complex in medical device lifecycles 
From the literature reviewed so far, we can conclude that there are multiple strategies for looping material 
flows in the medical device industry as regulated within the context of England, and these strategies have 
been successfully integrated in medical device businesses around the world. We also see how the process 
of decontamination is crucial to successfully looping material flows and the need for tailored business 
strategies for different products and product-life extension strategies. In the next section we explore the 
existing research in eco-design for medical devices in academic literature, and how these methods can 
complement an eco-effective approach to generate eco-effectiveness and eco-efficiency in the medical 
device industry.
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4.3 Review 3 - Epistemic Barriers and Opportunities  
4.3.1 Ecodesign for medical devices 
The previous two reviews have helped identify the regulatory and practical barriers and opportunities to 
eco-effective design of medical devices, as found in published literature. The third review focuses on the 
epistemic barriers and opportunities. In section 2.2, we covered the definitions, applications, relevance and 
strengths and weaknesses of eco-efficient and eco-effective design. While eco-efficiency has seen 
considerable academic rigour in the years since its relevance was established, academics are now finding 
the need to move from eco-efficiency to eco-effectiveness in order to meet the wider challenges of increased 
production and consumption around the world (Fernando and Evans, 2016; Barbiroli, 2006; Hermann et 
al., 2015). In their review, Rossi et al. (2016) found that there is a low uptake of eco-design tools and 
methods by companies due to the generic nature of these frameworks, and a need for more industry-tailored 
approaches. In our review of eco-design tools, we identified eco-design frameworks, methods and tools that 
contribute more specifically to the medical device field, and how their contribution is relevant to eco-design 
for medical devices in table 6. 
Table 6. Eco-design frameworks, methods, tools for medical devices 
S. No. Framework/ method/ tool Relevance 
1. Maturity grid assessment tool for 
Environmentally conscious design of medical 
devices (Moultrie et al., 2016) 
Emphasis on progressive reduction of environmental 
impacts. Useful in the value engineering phase of product 
development. 
2. Incorporating sustainability in decision 
making for medical device development 
(Hede et al. 2013) 
Helps contextualize over-arching criteria and factors 
determining sustainability of a medical device. Not enough 
focus on how the eco-optimization strategies integrate with 
the design process. 
3. Systemic Innovation in sustainable design of 
medical devices (Barbero et al., 2017) 
A generic system design approach to identifying 
opportunities in sustainable medical device redesign. 
4. Integrated eco-design decision-making for 
sustainable product development (Romli et al., 
2015) 
LCA-based product design methodology for improving 
sustainability assessment of products. 
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Analysis 
The four studies identified in the table above highlight the variety of methods and methodologies which 
have been explored in academic literature for eco-design of medical devices. The studies above are not only 
diverse in their approaches to integrating eco-design in the design of medical devices, but also provide 
macro and micro perspectives to the challenges, ranging from specific product-related improvements 
(Moultrie et al. 2016) to wider systemic challenges to sustainability in healthcare (Barbero et al., 2017). 
However, the studies do not explore the effectiveness of the approaches in bringing a positive impact to the 
environment. While a couple of them do highlight product-life extension as a relevant strategy (Moultrie et 
al., 2016; Barbero et al., 2017), they are generic in the descriptions used, and do not highlight how the 
medical device industry poses specific challenges to factoring these strategies in the design process. There 
is limited focus on the implications of the design of medical devices for the designers due to the wider focus 
on systems. Also, the studies do not focus on a specific context, thus providing much more wide-ranging 
generic models, which become a hindrance to design due to the variations in regulations applied to medical 
devices across the world. Thus, while these studies provide a positive thrust in the direction towards 
guidance on reducing environmental impacts of medical devices, a more focused approach for generating 
a positive environmental impact has not been explored. 
4.3.2 LCA and medical devices 
In section 1.3, we discussed the need for eco-effective design in the medical device industry, and the lack 
of such efforts, despite the growing examples of eco-effectiveness in the automotive, electronics, consumer 
appliances, and textiles industries. The need for eco-effective design strategies and the integration of 
environmental factors at the early stages of the design of medical devices can be beneficial in creating long 
term strategies for the medical device manufacturers, but this need for eco-effectiveness does not dilute the 
complementary need for eco-efficiency as well. The combined integration of eco-effectiveness through 
cradle-to-cradle approaches with the targeted eco-efficiency approaches of LCA and progressive 
improvement of the environmental credentials of a product has been found to be a recipe for success in 
other industries, and needs to be explored in the medical device industry too (Bakker et al., 2010; Bjorn and 
Hauschild, 2012; Niero et al., 2017). There are multiple examples in academic literature on the use of LCA 
for medical devices for analyzing sustainability impacts, and we analysed this literature to understand the 
specific applications of LCA in this field, as has been summarized in table 7. 
Table 7. LCA for medical devices 
S. No. Project Products studied Result 
1. Towards Sustainable Design for 
Single-use Medical Devices (Hanson 
and Hitchcock, 2009) 
Single-use dialyzer Improved material and energy 
efficiency. 
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2. The use of LCA to introduce life-cycle 
thinking into decision making for the 
purchase of medical devices in the 
NHS (Ison and Miller, 2000) 
Suction- receptacle The disposable version can cause 
greater environmental impact and 
incur greater financial costs for 
the NHS as compared to a 
reusable one. 
3. Assessing the environmental, human 
health, and economic impacts of 
reprocessed medical devices in a 
Phoenix hospital’s supply chain (Unger 
and Landis, 2015). 
1. Endoscopic Trocar 
2. DVT Compression Device 
3. Pulse Oximeter 
4. Scissor Tip 
5. Arthroscopic Shaver 
6. Ligasure 
7. Ultrasonic Scalpel 
Reduced environmental impacts, 
increased human health impacts, 
and significant cost benefits from 
reprocessed devices for the 
hospital as compared with single-
use disposable devices. 
  
4. Development and environmental 
improvements of plastics for 
hydrophilic catheters in medical care: 
an environmental evaluation (Stripple 
et al., 2008) 
Single-use hydrophilic urinary 
catheter (TPU and PVC 
versions along with new 
polyolefin version) 
PVC version performs better on 
energy use and emissions 
compared with the TPU version. 
Polyolefin version performs as 
well as PVC. 
5. Life Cycle Assessment and Costing 
Methods for Device Procurement. 
Comparing Reusable and Single Use 
Disposable Laryngoscopes (Sherman 
et al., 2018) 
Laryngoscopes Reusable versions outperform 
single-use disposable versions in 
environmental impact as well as 
cost to the hospital. 
6. Life-cycle assessment of single-use 
versus reusable surgical drapes 
(cellulose/polyethylene-mixed cotton 
system) (Dettenkofer et al. 1999) 
Surgical drapes The reusable versions required 
twice the energy and more water 
than the single-use versions and 
produced more CO2 emissions. 
The single-use version produced 
more waste. 
7. The financial and environmental costs 
of reusable and single-use plastic 
anaesthetic drug trays (McGain et al. 
2010) 
Anaesthetic drug trays Single-use trays cost twice as 
much, produce 15% more CO2 
and consume three times the 
amount of water, as compared to 
the reusable option. 
  
45 
8. Do single-use medical devices 
containing biopolymers reduce the 
environmental impacts of surgical 
procedures compared with their plastic 
equivalents? (Unger et al., 2017) 
LDPE, PP, polyisoprene, 
nitrile and neoprene-based 
products used in vaginal, 
abdominal, laparoscopic and 
robotic hysterectomies 
Replacing the plastics with 
biopolymers such as Guayule-
derived latex and PLA could 
reduce carcinogenic, non-
carcinogenic and respiratory 
impacts, but increase 
environmental impacts. 
9. Comparative life cycle assessment of 
reused versus disposable dental burs 
(Unger and Landis, 2014) 
Dental bur Reusable burs perform better on 
environmental impact as well as 
economic impact in scenarios 
where the autoclave machines are 
used at more than 66% capacity 
(20 burs or more). 
10. Environmental Impact of Surgical 
Procedures: Life Cycle Assessment of 
Hysterectomy in the United States 
(Thiel et al., 2015) 
Devices used in vaginal, 
abdominal laparoscopic and 
robotic hysterectomies. 
Major source of environmental 
impact was due to disposable 
material production and single-
use surgical devices. 
 Analysis 
In table 7, we can see a variety of medical devices which have been analysed for their environmental impact 
through LCA. A majority of the studies indicate that reused devices perform better than single-use devices 
in terms of environmental impact and costs incurred by the hospital. This validates the point raised in the 
previous review (section 4.2.1) regarding the economics of product-life extension having a detrimental 
effect on manufacturers, and a beneficial effect on hospitals. But, the factors considered and the impacts 
evaluated varied with each case. Thus, it is not appropriate to generalize the results as pro-reusable or pro-
single-use and apply them as indicators for policy or practice. But the applications of LCA in these devices 
does indicate that the analysis can generate context-specific information which can help hospitals develop 
appropriate policies as well as take an informed approach to invest in devices. Furthermore, the application 
of LCA can also provide targeted guidance to manufacturers for the development of eco-effective devices. 
For example, a life cycle impact assessment (LCIA) can help identify eco-toxicants and help eliminate these 
substances from the lifecycle at the early stages of the design of the device. While designers may not know 
the ecotoxicants being used in a device, LCIAs can help increase their awareness, and ensure the exemption 
of these substances from the life cycle of the devices they develop. A routine LCA of medical devices in 
use at specific hospitals can also help evaluate the performance of these devices, and enable manufacturers 
to explore opportunities for upgrading the devices. 
From this review of literature on eco-design in medical devices, we can draw two conclusions. The first is 
the lack of eco-effective frameworks, methods or tools for medical device design in existing academic 
literature. Due to the evidenced success of eco-effective measures adopted in other industries, and the 
limited or even detrimental effects of eco-efficiency measures adopted in the medical device industry, we 
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can postulate that the adoption of eco-effective measures can help develop long-term sustainability 
strategies for medical device manufacturers, and these strategies must be integrated in the early stages of 
design of devices to be relevant and effective. Thus, there is a need for eco-effective design strategies in 
the medical device industry of England to contribute to the challenges set by the Climate Change Act 
(2008). 
The second conclusion is that the use of LCA within these eco-effective design strategies can be beneficial 
for designers to become aware of ecotoxicants that must be avoided in the device lifecycles, as well as 
monitor the functionality of the devices in use to design maintenance and upgrade strategies, to ensure eco-
effectiveness of the device lifecycles. The combination of cradle-to-cradle and LCA has already been shown 
to be a promising eco-design strategy in section 2.2, and leveraging this knowledge in the medical device 
industry needs to be explored further.   
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4.4 Analysis - Phase 1 
Through the three reviews conducted, we have identified regulatory, practical and epistemic barriers and 
opportunities to eco-effective medical device design. The results from these reviews have been tabulated in 
table 8, highlighting the characteristics of eco-effectiveness that each point supports. Points that have not 
been highlighted affect eco-effectiveness in a holistic sense. 
Table 8. Summary - Phase 1 
(ecotoxicity, closing material loops, maintenance/upgrade of resource quality) 
S. No. Barriers Opportunities 
 Regulatory  
1. Lack of regulatory control on use or production of 
ecotoxicants beyond the production and use phase 
of a device lifecycle 
Product-life extension through reuse, reprocessing and 
remanufacture. Material recovery of electrical and electronic 
components, and potentially of non-infectious municipal waste 
2. Hospitals free to operate without any 
decontamination facility 
Non-active reusable transient devices have lower regulatory 
conformity requirements compared with single-use 
alternatives 
3. Mandatory disposal of protective and cleaning 
equipment 
No recertification required for minor upgrades in 
remanufactured devices. 
4. Waste management dominated by incineration and 
landfilling as most favourable options 
 
 Practical  
1. Risk of reinfection/cross-contamination Case studies of successful implementation of product-life 
extension strategies for medical devices.  
2. Higher cost to manufacturer, compared to single-
use devices 
Cost savings for healthcare providers 
 Epistemic  
1. Lack of eco-effective design frameworks, methods 
or tools for medical devices 
Use of LCIA to educate designers on ecotoxicants and their use 
in medical devices 
2.  Case studies of successful application of eco-effective 
measures in automotive, consumer appliance, electronics, 
textiles and energy industries 
We have also found that decontamination is a crucial process in the lifecycle of medical devices, which, if 
factored at the early stages of the design process, can determine the scope for product-life extension, 
material recovery, reduce the risk of reinfection, and reduce the costs for healthcare providers under certain 
circumstances. This project is focused on identifying opportunities and mitigating barriers for eco-effective 
design of medical devices. Thus, while advising on appropriate policy revisions may help improve the scope 
for implementing eco-effective decisions, it is beyond the scope of this project. The next phase of the 
research focuses on evaluating the wider life cycle implications of eco-effective design of medical devices, 
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and developing the principles of eco-effective design which can be used by manufacturers in the 
development of medical devices.  
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5. Phase 2 - Mapping Material Flows in Medical Device 
Lifecycles 
The second phase of this project uses the literature reviewed in phase 1 to develop a lifecycle inventory 
map of the material flows of medical devices. To understand how the regulatory policies interact with the 
existing practices in the lifecycles of medical devices, the information was mapped to visualize the flow of 
materials through the lifecycle of a medical device. This visualization helped better understand the 
interactions of the various stakeholders involved, the pathways available for product life extension and 
material recovery and how the barriers and opportunities to product life extension played a role at various 
stages of the life cycle of a medical device. 
The mapping of material flows was conducted in adherence with the material flow analysis process as 
explained by Bringezu and Moriguchi (2002). The process involves defining the goal and systems, 
analysing the processes involved, accounting and balancing the various inputs and outputs, and modeling 
the system to evaluate the desired outcome. In this study, we define the system boundaries as the lifecycle 
of medical devices within the regulatory framework applied in England, and the goal is to develop insights 
on eco-effective design of medical devices through the visualization of material flows. The second goal of 
this exercise is also to visualize the ideal flow of materials in an eco-effective system from a cradle-to-
cradle perspective, and thus understand the barriers and opportunities in attaining eco-effective biological 
and technical material loops. Bringezu and Moriguchi (2002) suggest a quantitative approach to accounting 
and balancing the flow of materials between processes based on the law of conservation of mass, but our 
interest in this study is more to do with the relationships between regulations, stakeholders, the processes 
involved, and the substances used or generated, rather than the quantities of these substances. Thus, in this 
phase we analyse these material flows from a qualitative perspective, rather than a quantitative one as 
proposed by Bringezu and Moriguchi (2002). Furthermore, the modeling phase is limited to a static map of 
the material flows and the process chains that develop, rather than a dynamic model, with specific case 
studies and quantitative figures. The aim is to understand the implications of the lifecycles of devices, and 
the interaction between various elements rather than to evaluate specific cases. 
The lifecycle inventory and system boundaries have been developed factoring the medical device policies 
in place, the material flows for medical devices as developed by Ison and Miller (2000) and the lifecycle 
inventory for consumer products as developed by Lu et al. (2011). In their study, Ison and Miller (2000) 
use an LCA of reusable and single-use suction receptacles to develop a holistic decision making process 
  
50 
for the NHS procurement policies and develop a simplified understanding of the cradle-to-grave lifecycle 
of a medical device. Lu et al. (2011) propose a sustainable product design process model based on lifecycle 
analysis for functional, environmental and economic evaluations. In their study, they depict a typical 
product lifecycle structure which corroborates the cradle-to-grave model as proposed by Ison and Miller 
(2000) and suggest the integration of product life extension and material recovery processes. By applying 
the regulatory requirements for medical devices, we developed a simplified medical device lifecycle 
inventory map that identifies the processes involved in the various stages of the lifecycle of a medical 
device, the associated stakeholders involved, and the regulations guiding these processes. The following 
section elaborates on the map, followed by an analysis of its implications on eco-effective medical device 
design. 
5.1 Structure of the map 
In order to analyse material flows in the lifecycle of a medical device, we identified crucial processes used 
in the construction, maintenance, and destruction of the device. Each of these processes, from the extraction 
and synthesis of the raw material to the end-of-life disposal of the device may involve the input and output 
of one or more resources. While some resources act as catalysts to the process, some are integral 
constituents of the device itself and some are by-products produced as part of the process. 
 
Figure 9. Elements of the map 
The map is composed of a combination of two elements; nodes and arrows (Figure 9). The nodes depict 
processes which resources may go through in the life cycle of a medical device, and the arrows depict the 
transition between processes, often being transport and storage of the resources used. The arrow length does 
not communicate the transport distances or the storage times involved, and is purely representational. The 
map as a whole depicts the various processes that define the various resource states of a medical device in 
its lifecycle. 
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Figure 10. Structure of the map 
Figure 10 shows the relationship between the arrows and the nodes. A typical process receives certain 
resource inputs, and produces certain resource outputs. The inputs can be classified into two categories; 
primary and secondary. The primary resource refers to key resources that are constituent elements of the 
medical device. This may refer to metals, polymers and synthesised materials used to create the device 
itself. The secondary resources are not integral to the device itself, but play an important role in the 
transition of a medical device from one process to another. This may refer to catalysts like water/steam, 
disinfectants used for decontamination, or even chemicals used in the process of synthesising new polymers 
for manufacture. The primary resource input and primary resource output may not be the same in every 
case. Similarly, the secondary resource input and the secondary resource output may not be the same either. 
A primary resource input may become a secondary resource output, and similarly a secondary resource 
input may become a primary resource output, depending on the process. 
Every process is regulated by a specific policy, and typically has a specific stakeholder involved. Depending 
on the device, the process and the context, the stakeholder may vary, but the regulation does not change. 
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For some processes, there are a few options prescribed by the regulations which are provided in smaller 
circles labelled option 1, 2 and 3 (Figure 10). 
5.2 Medical device material flows 
Figure 11 depicts a network of resource cycles that are legally and practically applicable to medical devices 
in England. Figure 11 visualises all possible resource cycles that constituent elements of a medical device 
can go through, along with the stakeholders involved, the regulations enforced and the possible options for 
specific processes as defined by the regulations. This also helps analyse existing medical devices and their 
life-cycles, providing a visual that can suggest resource-life extension strategies possible for the device.  
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Figure 11. Mapping the medical device resource cycles 
A typical cradle-to-grave lifecycle for a single-use medical device would be as provided in Figure 12. 
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Figure 12. Lifecycle of a single-use disposable device 
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In this six or seven-step life-cycle, every step can have multiple strategies associated with it. For example, 
depending upon the materials required to build the device, and the state of those materials, the material 
extraction process may vary. Similarly, different manufacturing and packaging strategies may suit different 
contexts, and these contexts may vary depending upon the scale of manufacture, the size of the device, the 
financing of the process and supply chain logistics, but these are concepts common to most devices, whether 
they are medical or not.  
A single-use device may be procured pre-sterilized, in which case it can go straight to the use phase, or it 
can go through a decontamination process before being used, as can be seen in figure 12. From the 
procurement stage onwards, the practices in the medical device ecosystem are nuanced and specified by the 
regulatory framework. These nuances have been elaborated further below.  
5.2.1 Procurement 
For procurement, there are three different methods available (Figure 13). The first is a standard purchase 
from the supplier. In this situation, the healthcare provider buys a device from a supplier, effectively owning 
it, until it is disposed of. The alternative to purchasing is renting a device from a supplier or another Trust 
for a limited amount of time. In this case the device is not owned by the user, and so the user pays the owner 
a fee for using the device over the stipulated period of time. The device must be returned to the owner in 
the same condition as it was procured, and so this procurement strategy works only with reusable devices 
(Figure 14). This also ensures that if a device is rented, it cannot be disposed of or consumed in any way, 
and must be returned to the owner. 
 
Figure 13. Procurement strategies for medical devices 
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Figure 14. Lifecycle of a rented medical device 
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The last alternative is donation, where the device is purchased by another organization and is provided to 
the healthcare provider for free. In this case the healthcare provider owns the device, but has not purchased 
it from any source. WHO (2016) identifies many advantages and disadvantages to donation of medical 
devices. Although medical device donations happen mostly in good faith, and as an act of humanitarian aid, 
sometimes the procedures can fail due to insufficient collaboration and understanding between the donor 
and the receiver. WHO has identified some of these hurdles and provided guidelines for donations and a 
list of known organizations that actively participate in the donation of medical devices (WHO, 2016). 
5.2.2 Decontamination 
The decontamination procedures are crucial to the safe use and handling of medical devices. These 
procedures vary with the devices being used, and are categorised based on the risk that the devices pose on 
the patient. Thus, decontamination procedures are often guided by medical device manufacturers, and create 
a unique decontamination-use cycle which is a key factor that defines medical device lifecycles (Figure 
15).  
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Figure 15. The decontamination-use cycle 
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The decontamination policy at the Royal Devon and Exeter NHS Foundation Trust (2018) is one such 
example which outlines this relationship between decontamination and risk to patients in the form of the 
following algorithm (Figure 16). 
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Figure 16. Algorithm for choosing the appropriate decontamination process 
(adapted from Royal Devon and Exeter, (2018)) 
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Decontamination strategies can fall under three main umbrella concepts, namely cleaning, disinfection and 
sterilization (Figure 17). The decontamination cycle as prescribed by the MHRA in HTM 01-01 highlights 
the position of these concepts in a typical decontamination-use cycle for a reusable medical device (DHSC, 
2016a). The algorithm above, further emphasises on the need for a combination of decontamination 
strategies that may be required for specific medical devices, depending upon the risks posed to patients, as 
well as the materials used in the device, and the appropriate sterilization techniques required for these 
materials. Figures 18 to 21 indicate the resource cycles developed for different levels of risk posed by 
medical devices. 
 
Figure 17. Decontamination strategies for medical devices 
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Figure 18. Decontamination cycle for reusable medical devices 
 
Figure 19. Decontamination cycle for low risk of infection 
  
63 
 
Figure 20. Decontamination cycle for intermediate risk of infection 
 
Figure 21. Decontamination cycle for intermediate/high risk of infection 
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The decontamination processes applied to devices are not just dependent on the guidelines of the 
manufacturer, but also depend on the hospital infrastructure available. Thus, these guidelines may vary 
from hospital to hospital.  
5.2.3 Use 
There are three main criteria which differentiate medical devices from each other. These three criteria 
further affect the classification of the devices, and thus, also determine the regulations that the devices must 
conform to. The first, and most critical aspect of the use of a medical device is the amount of contact the 
device has with the patient’s body. Depending upon the requirement, a device may be non-invasive, 
invasive or surgically invasive. The difference between an invasive and a surgically invasive device is that 
an invasive device may enter the body through natural orifices and stoma while a surgically invasive device 
may penetrate through the skin or mucosal layer. The invasiveness of a device significantly determines the 
criticality of the device, and the potential to reinfect a patient due to the use of non-sterile equipment. Thus, 
surgically invasive devices must be sterilized before being reused, rather than only being cleaned or 
disinfected. 
The second criteria for classifying the risk level of a medical device is the duration of use. The duration of 
use may vary from upto 60 minutes (transient use) to between 60 minutes and 30 days (short-term use) or 
more than 30 days (long-term use). Devices like surgical equipment are typically used at the time of the 
surgery only, and thus count as transient use devices, whereas implants may be used for over six months, 
and thus may be classified as long term use. Depending on the invasiveness of the device, and its duration 
of use, the appropriate decontamination and disposal strategies may be affected. For example, a ventilator 
has multiple components, some which are invasive, and others which are non-invasive, but the device itself 
is a long-term use device. The invasive components are either made disposable, or must be sterilized for 
reuse. The non-invasive components such as the control unit may be disinfected and reused for new patients. 
Thus, different components can have different lifecycles depending on their use, and can thus be designed 
for different resource life extension strategies.  
The third criteria, used mainly by care providers for decontamination logistics, is the number of use cases 
for a device, namely single-use, single-patient and reusable. Single-use devices must be disposed of 
immediately after use, and cannot be reused. Single-patient devices can be re-used for one patient, but must 
be disposed of once the use for that patient is completed and it must follow the decontamination 
requirements as prescribed by the manufacturer. A reusable device can be used more than once as long as 
the due guidelines on decontamination are adhered to. In case any device is not in a reasonable condition 
for use, it must be disposed of as prescribed by the supplier. Under UK guidelines instructed by the MHRA, 
all three use-case devices can be reprocessed or remanufactured so long as the appropriate policies are 
followed (MHRA, 2016; 2018).  
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Figure 22. Use strategies for medical devices 
Figures 23 depicts the potential lifecycles for reusable devices. 
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Figure 23. Lifecycles of a reusable device 
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5.2.4 Reprocessing 
As described earlier, reprocessing includes the decontamination, refurbishment and subsequent packaging 
of a used medical device (MHRA, 2018). This may be performed for reusable as well as single-use devices. 
The reprocessing of single-use devices is now recognized by the EU regulations (EU, 2017), and although 
not encouraged by the MHRA, it is legal as long as the device ensures the same standards of quality and 
safety as that of a new device. Reprocessing may be conducted on-site by the hospitals, and follow the same 
life cycle as a reusable device. But if the product needs to be refurbished at a specialist facility, then the 
device must be transported to the reprocessor and re-enter the supply chain through the procurement route. 
If a device cannot be maintained, or reused, then this is the next best resource-life extension strategy. 
5.2.5 Remanufacture 
Remanufacturing involves the refurbishment and upgrade of a used device, making the device equal or 
better in terms of its performance and value (MHRA, 2016). This may involve a change in components, 
repair of components, and even the upgrade of components. The MHRA approves remanufacturing of 
medical devices, as long as the quality and safety standards are maintained. The EU regulations enforce an 
approval system by which a remanufactured device is deemed to be the same device if the upgrades do not 
significantly change the quality and safety standards of the device (EU, 2017). In case an upgrade 
significantly changes the quality or safety of a device then it must be regulated as a new device, and thus 
require certification either for the new components or for the device as a whole. Remanufacturing is further 
regulated for single-use devices by ensuring that the remanufacturing agency is held responsible for the 
safety and efficacy of the device.  
5.2.6 Recycle 
Recycling is very tricky for medical devices, as it coincides with the standard end-of-life procedure of 
disposal. As the focus in a healthcare provider is to reduce reinfection rates, there is a tendency to process 
most of the medical waste either for incineration or appropriate landfilling. The exception to this rule is 
devices containing batteries, which need to be segregated due to the hazardous nature of the substances 
they are composed of, and the chances of batteries exploding if processed by incineration (EU, 2012; 
DHSC, 2013b). Based on the policies and the practice studied in this research, the systems for appropriate 
segregation of waste to enable recycling of key materials are well in place, but there is no incentive for 
clinicians to promote recycling when it does not affect their practice or their environment.  
There is also a growing concern for implants and the possibility of recycling components from implants 
used by patients who have now deceased. For patients who have deceased naturally, there are multiple 
strategies for final disposition of human bodies, including cremation, biodegradation through natural or 
chemical processes, and preservation for research. The bodies that contain implants and are cremated or 
degraded often release toxins into the air, water and soil as the implants themselves are not designed for 
those end-of-life strategies. In the UK, the MHRA has introduced some policies where implants can be 
checked for, before disposition by the burial office, but there is little data available to prove how effective 
this system has been (DHSC, 2013). 
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5.2.7 Bio-absorption 
The bio-absorption route for therapy, diagnostics or monitoring is a relatively new phenomenon which has 
occurred with the advancement of technology and the ability to mimic human organic matter. In terms of 
regulations, bioabsorbable medical devices straddle the boundaries of medical devices and pharmaceuticals, 
having both physical as well as chemical interactions with the human body. There are now bioabsorbable 
implants being developed for targeted drug delivery (Rouselle et al., 2019). Based on the studies conducted 
so far in the medical device resource cycles, this route seems to be the only known process of cycling 
resources through a biological cycle. As knowledge and scientific progress furthers bioabsorbable 
healthcare, this could become an important method of reducing waste, and providing targeted treatment for 
specific clinical problems (Rouselle et al., 2019). 
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Figure 24. Lifecycle of a bioabsorbable device 
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5.2.8 Disposal 
As explained earlier in the Health Technical Memoranda, disposal of medical waste (infectious and non-
infectious) eventually comes down to two options; incineration followed by landfilling, and direct 
landfilling (DHSC, 2013b). In both these scenarios, the resources are destroyed and disposed of in zones 
from where they are not recovered. These graveyards of potentially useful resources are now mixed in 
concentrations where individual materials and substances cannot be feasibly segregated and recovered. 
 
Figure 25. Disposal strategies for medical devices. 
In an ideal eco-effective system, there is no ultimate disposal of resources, and all material flows can be 
looped, maintained or upgraded for alternate uses. The ultimate landfilling of waste is considered by 
regulations as a safe disposal strategy, but there is no consideration given to the potential hazards of air, 
water and soil pollution due to incineration and landfilling.  
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Figure 26. Ideal state of resource cycling in medical devices 
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5.3 Key aspects of the map 
From the perspective of adhering to the cradle-to-cradle concept of technical and biological metabolisms, 
we have identified three aspects of the medical device material flow cycles which are important and 
necessary to be factored in the design process.  
1. The decontamination-use cycle: As provided in HTM 01-01, this is a key cycle that enables and 
(on most occasions) disables reusability of a device. If a device is not designed for 
decontamination, or is poorly designed for decontamination, it is in the interest of the healthcare 
provider to dispose of the device to prevent the risk of reinfection. A key aspect of the lifecycle of 
a medical device is the requirement of decontaminating the device before use, which is typically 
absent from most product lifecycles. 
2. Lack of a biological nutrient cycles: The strict regulations for the segregation and disposal of 
medical waste ensure that all anatomical, infectious, hazardous and offensive waste is 
decontaminated and disposed of, preventing any cycling of biological nutrients. The only 
exception to this rule is the bio-absorption and bio-dissemination of a product, which has only 
been added recently to the regulations due to advances in the field of bio-absorbable materials. 
3. The necessity of linear material flows in healthcare: Although the ideal scenario for a circular 
economy should be that all resources are cycled through either technical or biological cycles, in 
the healthcare industry, there is a necessity for one specific category of nutrients to remain in a 
linear system, which is the pathogenic nutrients. Any bacterium, virus, or fungus that may pose a 
threat of reinfection must be destroyed. This aspect of decontamination ensures that certain 
elements will always be destroyed instead of being cycled in a healthcare system. 
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5.4 Analysis - Material flow mapping  
From the above discussion, we can identify three insights that affect the implementation of cradle-to-cradle 
design of medical devices.  
The first point corroborates our identification that decontamination is crucial in the medical device industry, 
if material flow loops have to be created through any of the product-life extension or material recovery 
strategies that are available. The stakeholders typically involved in the process of decontamination are 
hospitals, in their reuse of devices, and manufacturers and reprocessing companies, for product-life 
extension strategies. But the design of a device and thus the manufacturer determines the appropriate 
decontamination strategy for a device. Therefore, while designing for decontamination may be considered 
as an opportunity for product-life extension and material recovery, the lack of decontamination facilities 
promotes single-use and disposal of devices, contributing to waste. In either case, it is a crucial factor that 
must be considered at the design stage to maximize chances of eco-effectiveness of the device. 
The second point is regarding the lack of biological cycles available for medical devices, apart from 
bioabsorbable devices. The regulations enforce the incineration of all biological material that is found 
through diagnosis, or treatment (DHSC, 2013b). Thus, unless the material is absorbed by the patient, it must 
be incinerated, preventing the feasibility of safely re-entering the natural biological cycle. Effectively, this 
means that unless a device is bioabsorbable, it must be designed with technical nutrients if it has to be eco-
effective, and if the device consists of biological nutrients, they must all be absorbed by the patient. All 
non-bioabsorbed biological nutrients will be incinerated, or decontaminated and landfilled, producing GHG 
in either case. This point factors more as a regulatory limitation or constraint to eco-effective design, rather 
than a barrier. 
The third point, which goes against the principles of cradle-to-cradle design is that due to the presence of 
pathogenic substances in the lifecycle of a medical device, the regulations demand that these substances 
must undergo a cradle-to-grave lifecycle. This point also validates one of the practical barriers identified in 
Phase 1 regarding the risk of reinfection due to product-life extension without sufficient decontamination 
of the device (refer to section 4.2.1). The pathogens cannot be cycled due to the dangers of reinfection that 
they pose to humans. This is true not only for the pathogens found in the devices, but also for the cytotoxic 
and cytostatic pharmaceuticals and radioactive waste, which must be treated as waste, even if the rest of 
the elements of the system develop a cradle-to-cradle model (Figure 6, p. 47). Thus, there can be no truly 
eco-effective, cradle-to-cradle system in healthcare institutions despite cradle-to-cradle design of medical 
devices. This also reinforces Bjorn and Hauschild’s argument (2012) that the concept of perfect resource 
cycles is still a utopian idea as even in nature there are no perfect nutrient flows, and the improper replication 
of these flows can sometimes even be detrimental to the environment. The possibilities for developing a 
cradle-to-cradle system of medical devices is to either decontaminate the pathogenic substances and safely 
re-introduce them to biological cycles, or to upcycle the incinerated and landfilled waste produced in a 
useful manner. Both the scenarios depicted above are beyond the system boundaries studied in this project, 
but may prove to be worthwhile areas for future research. 
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Through the mapping of material flows within the system boundaries of medical devices in England, we 
find that there are multiple opportunities to create these flows, and reduce the waste of resources in this 
industry. Within the limitations of working with pathogenic and hazardous substances, there are multiple 
avenues to explore for eco-effective medical device lifecycles. Yet, our review of academic literature 
suggests while eco-effective measures have been explored in other industries, there are no such supported 
references for the medical device industry. 
We use the insights from the barriers and opportunities identified in phase 1 and the insights from mapping 
of material flows in phase 2 along with appropriate design strategies to propose the principles of eco-
effective design for medical devices. A framework, based on the principles, provides a simplified approach 
to eco-effective design of medical devices, as elaborated in the following chapter. 
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6. Principles of Eco-Effective Design for Medical Devices 
In phase 1, we answered the first of the two research questions of this study, identifying the barriers and 
opportunities to eco-effective design of medical devices. We further gained some insights on the available 
strategies for implementing eco-effective characteristics in medical devices in phase 2 by mapping material 
flows in the lifecycles of medical devices, along with the stakeholders involved, and the regulations to 
govern them. To answer the second research question, we use the barriers, opportunities and insights from 
phase 1 and 2 to develop the principles of eco-effective design for medical devices. These principles build 
on the opportunities for implementing eco-effective design of medical devices, mitigate the barriers to 
implementing eco-effective design of medical devices and support the insights on eco-effective design of 
medical devices as evidenced in the mapping of material flows. The principles further provide the 
foundations for integrating eco-effective design in the design process for medical devices.  
1. No known ecotoxicant must exist either as a primary or secondary resource throughout the lifecycle 
of a medical device. All new ecotoxicants discovered and found in the lifecycle of a medical device 
must be eliminated and the device redesigned as required. 
2. A medical device must be designed for appropriate and successful decontamination. This may 
depend on the level of risk posed to the patient, materials used in the device and the effective 
decontamination technologies available.  
3. A medical device must be designed for the maintenance and upgrade of the quality of resources 
used and to prevent the downgrading of the resource quality. Thus, the components and overall 
assembly must be designed for reuse, repair, reprocessing, remanufacture, recycling or as many of 
the above as possible. 
Figure 27 illustrates how these principles relate with the barriers and opportunities identified from phase 1. 
It must be noted that the epistemic barriers and opportunities have not been factored in the principles, as 
they address the lack of sufficient knowledge. These have been addressed in the framework proposed 
following the principles in section 6.1. 
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Figure 27. Principles of eco-effective design for medical devices 
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The principles of eco-effective design for medical devices further adhere to the insights identified through 
the mapping of material flows in phase two. The importance of the decontamination-use cycle is reaffirmed, 
engaging with the need for designing devices for decontamination to maximize the opportunities for 
product-life extension and material recovery. The lack of biological nutrient cycles identified in the 
mapping of material flows has been addressed through the third principle, advising the design of devices 
for maintenance and upgrade of resource quality. The necessity of linear material flows due to pathogenic 
nutrients can be overcome by ensuring that the devices are designed for decontamination, maintenance and 
upgrade as proposed in principles two and three, thus providing opportunities for the recovery of non-
pathogenic materials, and reducing the waste that has been relegated for incineration and landfilling. 
Based on these principles, we proposed a framework that can be used to design medical devices for a 
positive impact on the environment, as an instance of how eco-effective design can be integrated with the 
design process of medical devices. 
6.1 Lifecycle Eco-Design Framework 
In section 2.1 we identified the requirements for the input phase of a medical device design process, and 
highlighted the lack of any requirements to mitigate environmental impact. We further identified three key 
characteristics of eco-effective design from the works of Frei and Züst (1997), as well as Braungart et al. 
(2007) which are essential for a product to produce a positive environmental impact. Furthermore, for these 
characteristics to be utilised effectively, they must be factored at the early stages of the design process, and 
so must be part of the project requirements at the early stages of the design process. To integrate these 
characteristics with the design process, we identified three principles to mitigate the barriers and use the 
opportunities within the regulatory and practical constraints of design of medical devices. Based on these 
principles, and the findings from phases 1 and 2, we propose a three-point framework that can be used for 
the eco-effective design of medical devices. Based on the environmental learning cycle proposed by Frei 
and Zust (1997) as well as the five-point framework for cradle-to-cradle design proposed by Braungart et 
al. (2007), we propose the Lifecycle Eco-Design framework as a method for integrating eco-effective 
design strategies with the design process. In table 9 below we can see how the environmental learning cycle 
and the cradle-to-cradle design concept cover the various phases of the iterative process of eco-effective 
design in three steps, as listed under the column Lifecycle Eco-Design Framework. We further highlight 
how these three steps work towards integrating the characteristics of eco-effective design. 
Table 9. Three-point Lifecycle Eco-Design Framework 
S. No.  Conceptual framework Lifecycle Eco-Design 
Framework 
Characteristics of Eco-Effective 
Design 
 
Environmental Learning Cycle (Frei and Züst, 1997) 
 
 
Lifecycle mapping 
 
1. Definition of the function 
2. Approach to solution 
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3. Material and energy flows 
4. Environmental impact Identify and eliminate 
ecotoxicity Elimination of known toxicants 
5. Impact assessment 
6. Causal analysis 
 
Cradle-to-cradle design (Braungart et al., 2007) 
1. Free of... 
2. Personal preferences Apply eco-effective 
design strategies Closed loop material flows 
Ensuring the maintenance or upgrade 
of resource quality 
3. The passive positive list 
4. The active positive list 
5. Reinvention 
The critical analysis of policies helped identify potential product life extension strategies that can be 
implemented for medical devices and the practical barriers of implementing them (refer to section 4.1.1). 
The mapping of material flows in phase 2 provides a visual understanding of the policies and stakeholders 
involved at various stages of the lifecycle of medical devices, and how these product life extension 
strategies work within the lifecycle of a medical device (refer to chapter 5). In order for a device to be eco-
effective, it must be designed to create material flows that are cyclic. As observed in Phase two, this can be 
accomplished for medical devices if the material flows fit in the process chains of the material flow map. 
Thus, the development of a medical device must include mapping of material flows as the first step towards 
eco-effective design. 
Although a device may be designed to be cyclic in its use of resources, if it exposes humans or the 
environment to toxic or harmful substances through its lifecycle, then they must be eliminated from the 
lifecycle. With a definite understanding of the processes used on a medical device throughout its lifecycle 
and the ecotoxicants involved, designers can use the understanding of the potential lifecycle of a medical 
device to eliminate toxic resources from the lifecycle by visualizing the resource flows and identify the 
source or use of toxic substances, and find appropriate non-toxic replacements. Fortunately, this process 
becomes easier with a continuously updated database which can be found in most lifecycle assessment 
softwares. Conducting a lifecycle inventory can also help identify the inputs and outputs from a system, 
developing more detail in the material flow map. But, it should be made clear that the aim is not to quantify 
the amounts and develop exact impact assessments, for which more detail is required. This framework is 
intended to be used at the early stages of the design process, developing functionally sound material flows 
and ensuring the product-life extension and material recovery strategies are integrated with the design 
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process. The ecotoxicant replacements identified must then be analysed through the hierarchy of design 
strategies to identify how the design can accommodate the replacements and yet be eco-effective. 
After eliminating ecotoxicants from the lifecycle, eco-effective design strategies must be identified and 
applied. The EU Waste Framework Directive (2008/98/EC) provides a waste management hierarchy which 
builds on resource life extension strategies as methods of preventing and reducing waste generation 
(European Commission, 2008). In their work, Bakker et al. (2014) use this hierarchy to identify the design 
strategies that help achieve the goals of this framework. Bocken et al. (2016) further identify the different 
design strategies and business strategies to slow the resource loops, close resource loops and narrow these 
loops to maximize the value of the resources in use, and minimize the requirement of fresh resources to 
provide the required value. Based on the analysis and insights from phase 1 and 2, we developed a hierarchy 
of design strategies that help designers develop medical devices for maximum product life extension, and 
material recovery (Table 10). 
Table 10. Hierarchy of design strategies for eco-effective medical device design 
S. No. Hierarchy Definition Design Strategy 
1. Decontamination “A process which removes or destroys 
contamination and thereby prevents micro-
organisms or other contaminants reaching a 
susceptible site in sufficient quantities to initiate 
infection or any other harmful response.” 
(MHRA, 2016, p. 9). 
Design for Decontamination 
(Design for cleaning 
Design for disinfection 
Design for sterilization 
Design for dis- and 
reassembly) 
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2. Reprocessing 
(also applies to 
maintenance and 
repair) 
“Where a person, institution or organisation 
undertakes processes on a used device in order to 
allow the safe reuse of the device. The processes 
may include cleaning, disinfection, sterilization, 
as well as testing and restoration of the technical 
and functional safety of the used device. Re-
processing should only be on a multi-use medical 
device, in line with the manufacturer’s 
instructions for use” (MHRA, 2016, p. 10). 
Design for decontamination 
Design for slow resource loops 
(Design for reliability and 
durability) 
3. Refurbish 
(also applies to 
remanufacture) 
“The complete rebuilding of a device already 
placed on the market or put into service, or the 
making of a new device from used devices, to 
bring it into conformity with the medical devices 
directives, combined with the assignment of a new 
lifetime to the refurbished device” (MHRA, 2016, 
p. 9). 
Design for Decontamination 
Design for slow resource loops 
(Design for ease of 
maintenance and repair 
Design for upgradability and 
adaptability 
Design for standardization and 
compatibility) 
4. Recycle “Any recovery operation by which waste 
materials are reprocessed into products, materials 
or substances whether for the original or other 
purposes” (EC, 2008, p. L312/10). 
Design for decontamination 
Design to close resource loops 
(Design for technological 
cycle) 
As has been identified in the medical device resource cycle map, decontamination is an important process 
that enables or disables the possibilities of product life extension of medical devices as no device can be 
used before a successful decontamination process. This is also reflected in the hierarchy of design strategies 
in Table 10. Furthermore, it was identified that pathogenic materials must be destroyed, and so the medical 
device industry cannot achieve complete circularity within the current policy framework, thus appropriate 
design strategies are required to ensure minimum but safe disposal of components, if no product life 
extension or material recovery strategies are feasible. 
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The process of mapping material flows, eliminating ecotoxicants and applying eco-effective design 
strategies creates a cyclic iterative process of eco-effective design in a medical device development process 
as described in figure 27. 
 
 
Figure 28. Lifecycle eco-design framework for medical devices 
The existing frameworks, tools and methods for eco-design of medical devices are applicable either at an 
eco-efficiency level, or a higher systems evaluation level. The lifecycle eco-design framework suggests an 
eco-effective approach to the design of medical devices and applies to factors beyond the use of the device, 
the production requirements, and the health and safety of the clinicians and patients (Vallet et al., 2013). 
By developing a visualization of the complex network of stakeholders, policies and design criteria, this 
framework engages not only with the concept of GHG emissions, but helps factor concepts such as toxicity, 
product-life extension and material cycling holistically within the practice of design of medical devices.  
6.1.1 Scope of application 
Based on the insights from phases 1 and 2, we can further define the scope of applying this framework in 
the design of medical devices through the following three points. 
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1. The framework is relevant to identifying design strategies for non-electrical and non-electronic 
components of a device. This is because the WEEE already necessitates the recovery of electrical 
and electronic components in a device (EU, 2012). Whereas, the regulations fail to enforce any 
significant recovery of non-electrical and non-electronic components, apart from gypsum, and 
photographic waste, especially if contaminated with pathogenic substances (elaborated in section 
4.1.2). 
2. To ensure the recovery of materials despite contamination with pathogenic substances, the 
framework suggests the application of design for decontamination for all components. While the 
decontamination and recovery processes may vary based on risk of use and material selection, it is 
important for all components to be designed for decontamination, and further recovery to ensure 
the looping of material flows. 
3. Within the regulatory framework applied in the UK, there are no biological material flow loops 
apart from bioabsorption. Thus, unless a device is designed for bioabsorption, its design for 
biological metabolisms is not only useless, but even detrimental to the environment if the device is 
incinerated (toxic emissions) or landfilled (anaerobic degradation). For this reason, the design of 
components for cascading or biodegradation is not suggested in the hierarchies of design strategies. 
Yet, with the increasing use of biopolymers to replace conventional plastics, it could be considered 
as a suitable strategy for cradle-to-cradle design of medical devices in the future (Unger et al., 
2017).  
The lifecycle design framework can be applied in design projects as a method for integrating eco-effective 
characteristics in the design of the device. An example of this application is provided in the next section. 
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6.2 Example - Redesign of the endotracheal tube 
In order to explain the use of this framework, we have provided an example of a redesign project which 
uses a step-by-step approach to understand the various stages of problem analysis to develop an 
understanding of possible resource life extension strategies through design. For this example, we take the 
case of Endotracheal Tubes (ET). ET are used to provide an air passage through the mouth or nose into the 
trachea (Ahmed and Boyer, 2019). It is often used for unconscious patients or in conjunction with 
ventilators or ambubags to support respiration. This single-use device primarily consists of a tube and an 
air inlet valve (Figure 29). We use the lifecycle eco-design framework to develop design strategies for eco-
effective medical device design and begin with mapping the lifecycle of ET (Figure 30, 31). 
 
Figure 29. Parts of an Endotracheal tube (Smiths Medical, 2019)  
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Figure 30. Step 1: Lifecycle Mapping 
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Figure 31. Mapping the lifecycle of ET 
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From this map we can identify two causes for concern from a toxicity perspective. The first concern is that 
the plasticizers used in the PVC for the manufacture of ET leaches into the body, and has toxic properties 
when exposed to humans. It has been evidenced that a plasticizer known as DEHP is used to provide 
flexibility to the otherwise rigid PVC, and it is toxic to reproductive, and respiratory health in humans, 
particularly newborns, due to its tendency to get stored in fat tissues (Chiellini et al., 2011; Gimeno et al. 
2013). The second cause for concern is that the process used for the disposal of ET is incineration, due to 
its contact with potentially infected pathogenic matter, and the incineration of PVC generates 
polychlorinated dibenzo dioxins and dibenzo furans, which are also carcinogenic when in contact with 
humans (Ahlborg et al. 1992; Kogevinas, 2001). Based on the framework developed, it would be important 
to develop design solutions which help eliminate the toxic elements from the lifecycle of the device. 
 
Figure 32. Step 2: Identify and Eliminate Toxicity 
Once a suitable solution has been found, the design process can move on to applying the eco-effective 
design strategies based on the hierarchy developed. The PVC tubing as well as the ABS inlet valve can be 
sterilized using Ethylene Oxide or Glutaraldehyde, and reused as evidenced by Yoon et al. (2007). But the 
two parts are fused together and thus may affect the disassembly, and potential repair, refurbishment, 
remanufacture and recycling of the device. An appropriate design solution is required to make the device 
easy to disassemble. Furthermore, if this device is to have multiple resource life extension strategies, then 
it must be designed for ease of upgrading (remanufacture), and ease of recycling. Figure 33 shows the eco-
effective design strategies applicable on this device. 
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Figure 33. Step 3: Identify Eco-effective Design Strategies 
Once a new iteration of the design has been developed, the device can be mapped once again to visualize 
the lifecycle and identify toxic elements which may have to be eliminated from the system (Figure 34). In 
Figure 35, we show the ideal eco-effective lifecycle of ET, based on the specifications established earlier.  
 
Figure 34. Iteration 2: Back to Step 1: Mapping of material flows 
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Figure 35. Ideal lifecycle of ET 
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Environmental sustainability in medical devices is a wicked problem with multiple stakeholders involved, 
and factors such as risk, benefits, and cost playing an important role in the resolution as explored in section 
1.2. The lifecycle eco-design framework provides the design perspective on resolving this problem by 
integrating environmental impact with the design process, but there are systemic challenges to 
implementing eco-effectiveness which need to be considered. Many of these challenges are beyond the 
design of the devices and context specific, such as the policies in place, the local infrastructure, feasibility 
of logistics and stakeholder commitment to change. Figure 36 uses the mapping of the ideal lifecycle by 
highlighting some of the stakeholder and regulatory challenges which have to be considered in such a 
systemic solution. More research is required to develop a detailed understanding of the other stakeholder 
perspectives on this problem complex. 
 
 
Figure 36. Systemic challenges to eco-effective design of medical devices 
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Mitigating these challenges requires more research and experimentation with eco-effective design of 
medical devices. To assess the framework, we engaged with experts in design for medical devices and 
design for sustainability to identify limitations of the framework, as well as the underlying principles of 
eco-effective design as reflected from this framework. 
6.3 Interviews 
In order to evaluate the framework, and the principles of eco-effective design of medical devices, semi-
structured interviews were conducted with experts in design for healthcare and design for sustainability. 
The experts were identified based on the relevance of their work either in design for environmental 
sustainability or design for medical devices (Table 11). A brief introduction to their work and background 
has been provided along with their consent letters in Appendix 2.  
Table 11. List of Interviewees 
S. No. Name Designation Affiliation 
1. Dr. Patrick Moriarty Adjunct Associate 
Professor of Design 
Monash Art Design and Architecture, Monash 
University 
2. Dr. Xiaoyu Yan Senior Lecturer in Energy 
and Environment 
College of Engineering, Mathematics and Physical 
Sciences, University of Exeter 
3. Jonathan West Research Fellow Helen Hamlyn Centre for Design 
4. Gianpaolo Fusari Senior Designer Helix Centre 
The interviews were designed to explain the motivation and methodology used to develop the framework 
and show an example of the application of the framework in the design of medical devices. The experts 
were provided with a document three days before the interview, detailing the framework and its application 
in medical device design. The document also contained the questions to be discussed in the interview. The 
interview would commence with a brief overview of the document and proceed with discussing the 
questions. Although the interview was designed for 15 minutes, in one case it extended to an hour long 
discussion. The document and the transcripts have been provided in appendices 3 and 4. A set of questions 
were posed to the interviewee to evaluate the framework and propose changes and alternative perspectives 
which could help refine the framework for testing in real-world design projects. 
6.3.1 Suggestions 
The following points cover some of the feedback received on the framework, and opens new avenues to 
take this research further.  
“Where does design end?” West, J. (2019) 
This framework is relevant when the role of design can go beyond the product itself, as Jonathan poignantly 
questioned, “Where does design end?”. He explained how consultants and design studios could only go to 
a certain extent of proposing design solutions to the client, especially when the project is initiated for a 
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specific aspect of the design or design research for a device/problem. This question furthers the intent with 
which this framework was created. The point of analysing lifecycles was for design to factor not just the 
device, but the system in which the device is produced, used, and subsequently disposed of.  
“An understanding of monetary flow is key to disruptive change in this market.” - West, J. (2019) 
A key concern that both Jonathan and Dr. Yan pointed out was how this framework connects with the 
financial viability of better resource-life extension strategies. Although concern for climate change and 
carbon emissions may be a strong motivator for better resource cycles, it is not the first concern. The first 
concern is financial sustainability of a business through the medical device. The framework developed in 
this research does not factor the finances involved in selecting alternative resource cycles, which would be 
an important factor driving decisions in the design and development of medical devices.  
Does the framework provide a quantitative comparison of concepts? 
At present, the framework is purely a visual and logical (qualitative) evaluation of resource lifecycles for 
medical devices. But Dr. Yan commented that a quantitative approach could improve the ability to compare 
concepts and improve decision-making strategies for sustainable medical device design and development. 
The three factors that become crucial in identifying sustainable solutions are cost, carbon emissions and 
circularity. But while cost, and carbon emissions can be quantitatively evaluated, circular economy is a 
field that still has no quantitative evaluation methods for concept evaluation. The existing circularity 
measures are dependent on a complete definition of the product, materials, and quantities. But this 
knowledge is not available at the early stages of the design process, thus making these indices and measures 
inapplicable for eco-effective decisions on circularity. 
“Is this an educational thing or how do you expect this to be used in practice? As a theoretical framework, 
it is much more effective at highlighting the higher level aspects, (influencing policy, maybe) than it is 
for design practice. For design practice… you may need more detailed steps” - Fusari, G. (2019) 
As Gianpaolo explained, the design process is fuzzy, and not linear. The approach he used in various 
projects, depended on the projects, and did not follow a strict order of events. The case with methods, tools 
and frameworks was also similar, wherein, they are used for specific cases and require prior training or 
knowledge. The question with this framework was that, although it covered the essential aspects to resource 
cycles in medical devices, it required more detail and a structured approach which could be used for specific 
use cases. At this stage the framework was more suited to build a case on how design has an important role 
in the production of medical waste, and this framework can be used to convince policy makers of the need 
for stricter standards in medical device design and development.  
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6.3.2 Analysis - Interviews 
The feedback from the interviewees was analysed through a SWOT analysis and tabulated. While some 
aspects of the analysis pertain directly to the framework, some aspects were more related to the principles 
of eco-effective design of medical devices itself. These insights have been discussed in table 12.  
Table 12. SWOT analysis of lifecycle eco-design framework 
Strengths The material flow map was found to be accurate based on the experience of the interviewees 
Weaknesses 
  
Using the framework requires making strategic design decisions beyond the product and the 
system 
No correlation with economic feasibility makes environmental impact an isolated outcome 
Opportunities 
  
Framework could be used as an educational tool for medical device designers on eco-effective 
design 
Framework can be useful in creating policy decisions regarding environmental impact of medical 
devices 
Threats Lack of quantitative outcomes from framework may deter designers from using it 
From the opportunities and strengths identified in table 12 we can see that the principles of eco-effective 
design of medical devices are well-supported by the framework. The interviewees found the material flow 
map to be accurate, and suggested that the theoretical basis of the framework was sound, and so the 
framework could be used for educating designers on eco-effective design of medical devices as well as to 
support policy decisions on the environmental impacts of medical devices. This helps validate the principles 
of eco-effective design developed earlier in this chapter. 
From the perspective of the framework, and its ability to capture the necessary information to enable 
manufacturers to design eco-effectively, two main concerns were highlighted. The first is the lack of 
integration of the framework with other factors involved in the development of a medical device, such as 
cost, risks, and benefits. For such an integration, the framework needs to be further contextualised to the 
processes developed and used by individual manufacturers, as it depends on the scale of operations, the 
expertise of the staff, and the vision of the management. The second concern was regarding the lack of 
quantitative outcomes from the use of the framework. It is important to factor that there is very little 
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information available at the early design stages, and so developing quantitative comparisons may be 
difficult, and even misleading if used inappropriately. These insights can be factored if the framework is 
developed further with manufacturers and contextualized through case studies, but these tasks are beyond 
the scope of this project.  
From the perspective of the use of the framework for eco-effective design of medical devices, the 
interviewees found the material flow map accurate based on their experience in the industry, and agreed 
with the need for a stronger focus on environmental sustainability in the medical device industry. This re-
affirms the validity of the material flow map developed in this research. Furthermore, the feedback also 
reveals that the implementation of eco-effective strategies and the use of such frameworks depends on the 
willingness of manufacturers to explore new design and business strategies. The implementation of changes 
to the product functions and other early stage decisions often is beyond the control of individual designers. 
This echoes one of the insights from the survey of medical device designers conducted by Moultrie et al. 
(2015), which identified the lack of client demands for design for environment as a barrier to the 
implementation of design for environment strategies in the medical device industry. While a few case 
studies have been identified in the reviews in phase 1 regarding product-life extension strategies applied to 
medical devices, more research may be required to convince manufacturers to transition from eco-
efficiency to eco-effectiveness. As the framework and the supporting example in this chapter indicate, the 
opportunities for implementing eco-effective design for medical devices is highly contextual and the 
success of these design decisions is dependent on the systems that can provide the necessary services, such 
as decontamination, repair, reprocessing, and remanufacture of devices. Beyond the conventional design 
criteria of usability, cost, risk and supply chain requirements, the success of eco-effective design depends 
on the systems that support the maximization of resource life and the elimination of toxic substances from 
the lifecycle. Thus, the design must factor the context, and the systems that can be effectively used to 
develop eco-effective medical devices which may involve internalization of expertise and systems or 
collaboration with third-party service providers (Fernando and Evans, 2015). More research is required to 
understand the perspectives of other stakeholders on the use of eco-effective design strategies for medical 
devices.  
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7 Discussion 
In this chapter, we discuss the research conducted in this project, with particular focus on the results 
obtained on our research questions. The first section of this chapter identifies the contribution to knowledge, 
and how the research justifies these contributions. The second section focuses on the limitations within 
which this research was conducted, and their relevance to the contributions to knowledge. The third section 
identifies prospects for future work not only for the progression of this study, but also for the knowledge 
gaps in the area of ecodesign for medical devices.  
7.1 Contribution to knowledge 
We revisit the research questions identified in section 1.2 and highlight how this study contributes to 
answering those questions.  
Research Question: How can eco-effective measures be integrated in the design of medical devices?? 
1. What are the barriers and opportunities to eco-effective design of medical devices? 
We arrived at this question due to the evidenced lack of literature that suggested the use of eco-
effective design practices in the medical device industry, despite the increasing relevance of eco-
effective practices to meet the environmental targets set by the Climate Change Act (2008), and the 
evidenced success of eco-effective measures applied in other industries. This point has been 
elaborated in section 2.2. The two phases of research conducted as elaborated in chapters 4 and 5 
provided insights on these barriers and opportunities. The findings reveal regulatory, practical and 
epistemic barriers and opportunities for eco-effective medical device design. While some of these 
findings have direct references in literature, others have been corroborated through the material 
flow mapping and framework development in phase 2 in chapter 5. We have compiled and tabulated 
these findings in the table below. 
Table 13. Barriers and opportunities for eco-effective design of medical devices 
(ecotoxicity, closing material loops, maintenance/upgrade of resource quality) 
S. No. Barriers Opportunities 
Regulatory 
1. Lack of regulatory control on use or production of 
ecotoxicants beyond the production and use phase 
of a device lifecycle 
Product-life extension through reuse, reprocessing and 
remanufacture. Material recovery of electrical and electronic 
components, and potentially of non-infectious municipal waste 
2. Hospitals free to operate without any 
decontamination facility 
Non-active reusable transient devices have lower regulatory 
conformity requirements compared with single-use 
alternatives 
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3. Mandatory disposal of protective and cleaning 
equipment 
No recertification required for minor upgrades in 
remanufactured devices. 
4. Waste management dominated by incineration and 
landfilling as most favourable options 
 
Practical 
1. Risk of reinfection/cross-contamination Case studies of successful implementation of product-life 
extension strategies for medical devices.  
2. Higher cost to manufacturer, compared to single-
use devices 
Cost savings for healthcare providers 
3. Manufacturers perceptions and demands  
Epistemic 
1. Lack of eco-effective design frameworks, methods 
or tools for medical devices 
Use of LCIA to educate designers on ecotoxicants and their use 
in medical devices 
2.  Case studies of successful application of eco-effective 
measures in automotive, consumer appliance, electronics, 
textiles and energy industries 
 
2. How can these eco-effective strategies be factored in the design process? 
In order to factor eco-effective design in the design process of medical devices, we used the insights 
from phases 1 and 2 to propose the principles of eco-effective design for medical devices as follows.  
1. No known ecotoxicant must exist either as a primary or secondary resource throughout the 
lifecycle of a medical device. All new ecotoxicants discovered and found in the lifecycle 
of a medical device must be eliminated and the device redesigned as required. 
2. A medical device must be designed for appropriate and successful decontamination. This 
may depend on the level of risk posed to the patient, materials used in the device and the 
effective decontamination technologies available.  
3. A medical device must be designed for the maintenance and upgrade of the quality of 
resources used and to prevent the downgrading of the resource quality. Thus, the 
components and overall assembly must be designed for reuse, repair, reprocessing, 
remanufacture, recycling or as many of the above as possible. 
The relevance of the insights from phases 1 and 2 on these principles has been elaborated in section 6.1. 
The principles have been applied to generate one instance of a framework to integrate eco-effective design 
strategies with the design process for medical devices, and the principles were validated through semi-
structured interviews with field experts. The interviews helped reassert the validity of the principles 
developed through this study.
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7.2 Limitations 
Context 
An important limitation that was planned in the methodology was the context of the research. The project 
was intended to study the regulatory framework in England to limit the variability in regulations and hence 
limit the variability in the answers to the research questions. The limitation ensured focused and less 
erroneous results, and ensured that the methodology was effective. As the Climate Change Act (2008) 
applies to the United Kingdom, it is possible to expand the context to all four member nations and explore 
how the variability in regulations affects the barriers and opportunities to eco-effective design within this 
context. 
Home healthcare 
It was consciously decided that the study would focus on medical devices used in healthcare institutions 
and not those used in home healthcare, as the inclusion of home healthcare would significantly increase the 
variability in material flows and end-of-life scenarios. Furthermore, as identified in phase 1, the regulatory 
framework on home healthcare is still not very well defined and there was not much literature available to 
validate material flows in home healthcare situations and the potential dangers of these flows. Yet, as the 
NHS tries to reduce the burden on healthcare facilities and increase at-home treatment, it is important to 
study how home healthcare develops without the decontamination and disposal support of hospitals. It 
would also be important to understand the environmental and health implications of home healthcare waste 
and develop appropriate strategies to mitigate these risks. 
Framework Validation 
The framework for eco-effective medical device design developed through this research is still in its early 
stages of development, and requires more validation for practical use in the medical device industry. The 
focus of this research was more on developing and validating the principles of eco-effective design for 
medical devices, and this framework was one instance of a strategy to mitigate the barriers and use the 
opportunities identified for eco-effective design of medical devices. Further research to develop the 
framework may include case studies with medical device design agencies, manufacturers and custom design 
projects with clinicians and healthcare providers. 
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7.3 Future Prospects 
Since this is only a first understanding of a complex problem, there are multiple opportunities and directions 
in which this research can be taken forward. This research forms the initiative for a deeper understanding 
of the practical hindrances and opportunities of eco-effective design of medical devices. In line with 
improving the understanding of sustainable design for medical devices, we identified potential directions 
to take this research forward. 
Stakeholders and value associated with medical devices 
The research conducted through this project has helped understand the resource flows in the lifecycles of 
medical devices. These resources are owned, used and consumed by different stakeholders, and their 
understanding of the value associated with a medical device is crucial to understand what strategies can be 
feasibly developed for product life extension and material recovery. There are multiple stakeholders 
involved through the lifecycle of a medical device, and these stakeholders have different concepts of value 
associated with the medical device and the resources used in its lifecycle. An understanding of the 
relationship between value cycles and resource cycles can help develop new insights on this problem. 
Financial implications of circularity in medical devices 
A key factor that requires more attention is the financial implications of circularity in the medical device 
ecosystem. Since a large part of decision-making is driven by cost, it would be interesting to embed cost-
analysis in eco-effective design approaches, to provide the designers with practical real-world simulations 
for comparing concepts on sustainability. 
Developing a quantitative tool for measuring circularity in medical device design 
While the Climate Change Act focuses on reducing GHG emissions, the eco-effective and cradle-to-cradle 
approach focuses more on resources as nutrients in cycles. Our current methods of using emissions as the 
sole criteria for tackling climate change can be misleading and counter-intuitive in some cases, and there 
are not many alternatives yet to compare nutrient cycles and their impact on the environment. More research 
is required in understanding how circularity can be quantitatively analysed at the early stages of the design 
process
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8 Conclusion 
Medical device design is a highly specialised and nuanced field requiring a collaborative interdisciplinary 
engagement of stakeholders, to produce highly regulated equipment for treatment, diagnosis, monitoring 
and rehabilitation of human beings. The process of developing a medical device is time and capital 
intensive, and this field has been successful in contributing to better care for a large proportion of our 
population. But in the past 200 years, a new challenge has emerged chronically endangering life, beyond 
the scope of treatment through medical care. As global temperatures rise, and we develop a scarcity of 
essential resources, a new and more sustainable approach to creating medical device lifecycles is required. 
The complexity of the problem is such that no linear solution exists, and a more practical approach would 
be necessary to resolve the problem for the stakeholders involved. While multiple strategies for eco-
effective design exist in academic literature, there is a lack of eco-effective strategies that specifically target 
the medical device industry. The literature indicates that factoring environmental impact at the early stages 
of the design process and using concepts of cradle-to-cradle can be a much more effective strategy in 
curbing environmental impacts than progressively reducing the use of resources, that continue to rise in 
demand due to increased consumption rates of a growing population. Despite the use and success of these 
strategies in multiple industries such as consumer appliances, automotive, and textiles industries, their 
application in the medical device industry was not found to be documented in published literature. This 
study explored the barriers and opportunities to eco-effective design of medical devices, and how eco-
effective strategies could be integrated with the design process.    
The research was conducted in two phases as elaborated in chapters 2 and 3, detailing the identification of 
regulatory, practical and epistemic barriers and opportunities to eco-effective design, and mapping the 
material flows in medical device lifecycles to visualize these barriers and opportunities. The first phase 
included three sets of literature reviews to establish the documented barriers and opportunities to eco-
effective medical device design. The first review used a critical analysis of the regulatory framework 
guiding the lifecycle of medical devices in England, highlighting the various product-life extension 
strategies, and the limited material recovery strategies available to use for looping material flows. The 
second review explored the practical barriers and opportunities to product-life extension and material 
recovery for medical devices as documented in various healthcare systems all over the world. A critical 
factor identified which influenced looping material flows was decontamination of devices. The risk of 
reinfection and costs incurred by manufacturers in developing material flow loops were also found to be 
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potentially discouraging for eco-effective design strategies. The third review looked at the current state of 
ecodesign knowledge as developed specifically for medical devices. Four such frameworks, tools or 
methods were identified which were intended specifically for medical devices, but none focused on eco-
effectiveness. Furthermore, multiple LCA studies on medical devices were found suggesting a potential 
application in the identification of ecotoxicants in medical device lifecycles. The barriers and opportunities 
for eco-effective design were identified and tabulated. 
Based on the information acquired through the first phase, the second phase used mapping of material flows 
as a method of visualizing the complex relationships between stakeholders, regulations and the various 
processes in the lifecycle of a medical device. This map also factored the potential product-life extension 
and material recovery strategies, along with a delineation of the biological and technical metabolisms. The 
mapping helped assert the importance of the decontamination stage of the lifecycle and its relevance to the 
successful extension of product life, material recovery or even safe disposal of a device. The presence of 
pathogenic substances posed a significant barrier to the recovery of material from disposal, relegating 
several materials to incineration or landfilling. Furthermore, it was identified that pathogenic nutrients must 
fundamentally be destroyed, and have no scope for re-entering biological or technical metabolisms due to 
the potential risk of reinfection or cross-contamination. Thus, a system engaging with pathogenic nutrients 
will always produce waste which must be destroyed (incinerated/autoclaved and landfilled in this regulatory 
context) and thus fundamentally fails the ideal cradle-to-cradle scenario. 
Based on the findings from phases 1 and 2, we proposed the principles of eco-effective design for medical 
devices. These principles provide a foundation for approaches to integrate eco-effective measures in the 
design of medical devices. The principles were used to propose one instance of a framework for identifying 
and applying eco-effective design strategies on medical devices. The framework was elaborated with an 
example of the redesign of an endotracheal tube and suggested what the ideal eco-effective cradle-to-cradle 
scenario in a medical device could resemble. The framework was further tested through face-validation 
interviews, and the feedback from the experts helped validate the underlying principles of the framework 
and their relevance to integrating eco-effective measures in the design of medical devices  
Future work in this area can include a deeper understanding of the stakeholder perspectives on the problem 
of eco-effective design of medical devices, and can entail value-mapping of medical devices through their 
lifecycles. More case studies of specific medical devices can help provide more specific solutions to the 
financial implications of eco-effective design in this industry. It would also be interesting to know how the 
regulations affect eco-effective design decisions in other countries and regions of the world.  
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This study provides an approach to engage with complex wicked problems through design research as has 
not been found in academic literature, and highlights the relevance of systems and contexts in the methods 
used. In a field where no simple solutions exist, a stronger focus is required on developing radical ideas and 
approaches and design methods which serve to execute them. These systemic problems cannot be solved 
in silos of disciplines and expertise and require a holistic understanding of the challenges faced by different 
stakeholders and a common platform to resolve them. Furthermore, this study engages with the complexity 
of the problem from a design perspective to increase the understanding of the problem rather than propose 
a simple unified solution. Problems of such a wicked nature require continuous development to improve 
the practice as well as inform the policies in a symbiotic manner. 
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Appendices 
Appendix 1 - Ethics application confirmation 
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Appendix 2 - Consent Forms 
Interviewee 1 - Dr. Patrick Moriarty 
“Dr Patrick Moriarty is presently an Adjunct Senior Research Fellow in the Department of Design at 
Monash University Australia and was also a part-time Senior Research Fellow with the Governance and 
Management of Urban Transport (GAMUT) group at Melbourne University from 2006-2013. For more 
than three decades he has researched urban transport and urban land-use planning, with emphasis on equity 
and ecological sustainability issues and his more than 120 papers, books, and book chapters are mainly on 
these topics. 
More recently he has also become interested in the climate change implications of different fuels/energy 
sources for both transport and electricity generation. This research is not only future-focused and 
interdisciplinary but also considers problems such as oil depletion and climate change in a global context. 
In 1982 he was seconded to the Ministry of Transport as a union-appointed member of the project team that 
set up the Melbourne Transport Authority. He also served on a government-appointed panel assessing the 
electric and magnetic fields associated with the proposed Richmond to Brunswick high-voltage power line 
in Melbourne in 1988. 
For six years in the 1970s, he taught civil engineering at Dar es Salaam Institute of Technology in Tanzania 
and carried out field research on low-cost housing. His post graduate degrees are in soil mechanics related 
to highway design, He is lead author of the 2011 book published by Springer ‘The rise and fall of the carbon 
civilisation’. He has been teaching and researching on the Caulfield campus of Monash University since 
1977.” (Moriarty, 2020) 
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Consent form 1 - Dr. Patrick Moriarty, Adjunct Associate Professor of Design 
Monash University 
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Interviewee 2 - Dr. Xiaoyu Yan 
“Xiaoyu is a Senior Lecturer in Energy and Environment at the University of Exeter and was previously a 
Research Associate at the Universities of Cambridge, Oxford and London, with a PhD in Mechanical 
Engineering. He is a member of the Renewable Energy Group in the College of Engineering, Mathematics 
and Physical Sciences and also part of the interdisciplinary Environment and Sustainability Institute, where 
he serves as Associate Director for Internationalisation & Partnerships. Xiaoyu is Co-Founder and 
Scientific Advisor of Minviro Ltd, a mining sustainability solutions specialist.” (University of Exeter, 2020) 
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Consent form 2 - Dr. Xiaoyu Yan, Senior Lecturer in Energy and Environment, 
University of Exeter 
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Interviewee 3 - Jonathan West 
“Jonathan has spent 13 years working in design in healthcare, and leads the Healthcare Research Space at 
the Helen Hamlyn Centre for Design at the Royal College of Art. Jonathan's research interests include 
design for patient safety and inclusive design. His work on a new resuscitation trolley for the National 
Patient Safety Agency won two Medical Futures Innovation Awards and completed successful clinical trials 
prior to manufacture. He has shaped high profile projects such as Design Bugs Out and Design for Patient 
Dignity with the Department of Health and Design Council, as well as supervising projects with partners 
ranging from ArjoHuntleigh to the Medical Defence Union. He was Design Lead on the EPSRC-funded 
project, ‘Designing Out Medical Error’. This three-year multidisciplinary project in collaboration with 
Imperial College, London, looked at the role design can play in reducing medical error on hospital wards. 
This award-winning project pioneered methods of collaboration and has resulted in a suite of designs for 
the hospital ward, and paved the way for the HELIX Centre, where Jonathan was seconded.  His work has 
been published internationally in journals, books and as papers.” (Royal College of Art, 2020a) 
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Consent form 3 - Jonathan West, Research Fellow (Helen Hamlyn Centre for Design), 
Reader in Healthcare Design 
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Interviewee 4 - Gianpaolo Fusari 
“Gianpaolo is an Industrial Designer with over eight years experience in product design and development 
in healthcare. He joined the Helen Hamlyn Centre for Design in 2010 and was a Senior Research Associate 
in the Healthcare Research Space. During his time at HHCD, Gianpaolo worked on several projects 
including: the Emergency Ambulance; initiatives to reduce violence and aggression in Emergency 
Departments and a portable workstation to improve safety, consistency, workflow and information 
management for General Practitioners. 
Since joining Helix Centre, Gianpaolo has applied his product design skills in different projects such as 
improving uptake to bowel cancer screening and reducing pressure ulcers caused by oxygen therapies. He 
currently leads a project in Neuro Rehabilitation where he is working with stroke survivors and clinicians 
to develop solutions to improve arm rehabilitation.  
Gianpaolo holds a joint MA/MSc in Innovation Design Engineering from the Royal College of Art and 
Imperial College London.” (Royal College of Art, 2020b) 
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Consent form 4 - Gianpaolo Fusari, Senior Designer, Helix Centre 
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Appendix 3 - Research Document for Interview 
This section consists of the slides in the research document presented to the experts for interviews. The 
following pages provide each slide in order. 
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Appendix 4 - Interview Transcripts 
(i) Interview with Dr. Patrick Moriarty 
Patrick: A few introductory comments. One, you’re studying English hospitals, perhaps you need to put 
in a sentence in, what happens if England leaves the EU. Because the regulations are for the EU. I don’t 
think it will change much. Secondly, I presume you are interviewing the environment officers at large 
hospitals in England, are you? Or some of them? 
Pranay: Not yet, so my interactions so far have been with people in the academic community in 
sustainability and the healthcare community. So, design for healthcare… 
Patrick: Yeah, so I’m just wondering it might be useful to, well not necessarily interview, but get the stats 
on, well you could interview them, but at the large hospitals like [] and so on in London, you’ll have 
probably designated environmental officers and you could talk to them, and ask them, you know, and 
especially it would be good to get the amounts of each of the different types of waste. And one type of 
waste you might want to look at is nuclear waste. Two years ago, we have a specialized cancer hospital 
here in Melbourne, Peter MacCallum [] and I’m fine now, but I did have bowel cancer, but part of the 
treatment waste radiation treatment. Hospital radiation waste are a very special case of medical waste. 
Again, you might just keep that in mind.  
I can’t agree more strongly with your circular economy. In my research, we call this Earth system science. 
Its looking at the impact of everything on everything and this is sort of what you’re doing, so I support 
that very strongly. Have you heard of people like Herman Daly and his steady state economy and so on, 
have you read anything on the circular economy itself? 
Pranay: Yes. Basically, my understanding of circular economy stems from, one, whatever the Ellen 
Macarthur Foundation has been doing, secondly, I took two online certificate courses on circular 
economy floated Conny Bakker from Delft University. Beyond that, its been about the current research 
happening at Imperial College London, Technical University of Denmark, and TU Delft. 
Patrick: Obviously you have covered that well. Now, I don’t think this is really important, but I would be 
intrigued to know if there were any rare earth materials used in medical waste. One of my areas is 
renewable energy, and platinum for instance for fuel cells or three way catalytic converters and the rare 
earths used in wind turbines and often in PV cells. There are concerns whether there is enough of that. I 
don’t know if there are any in medical instruments, but I’m just saying you would be aware of that. 
Probably wouldn’t be very important.  
Pranay: Yes, in medical devices right now one of the core concerns from a toxicity perspective and rare 
earth metals, one of the things is the use of more and more electronics in medical devices. So the rare 
earth metals that get used in microchips and controllers. So the concern here is, as the industry shifts to a 
more single-use disposable model a lot of these metals get either incinerated or landfilled. Most of these 
microchips and electronic media get destroyed. Secondly, as the industry shifts to a more implantable 
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model, we have more and more electronics getting implanted within the body, for monitoring, diagnosis 
and for treatment, there is this concern as to how efficient is the process of removing the implants, say for 
instance a patient passes away, how efficient is the system where the burial agency or the family members 
are known to actively connect with hospitals and inform them that this patient may have so-and-so 
materials in the body which could be salvaged for other purposes. SO that is another part of it. 
Patrick: Something I hadn’t thought of. What comes through with this is that you have thought about this 
a lot. In fact, there is not much I can give you. You’re doing a pretty good job I think. The only other 
comment I have on it is waste, classified based on ailment. You know, do certain treatments generate 
more waste than others, and what type.  
Pranay: I actually have some information on that, so basically what happens is, the two areas of treatment 
that produce the most amount of waste are cardiology and neurology. The reason is, any device that is 
developed for cardiac treatment, which may be invasive or any sort of treatment to the spine or to the 
brain, are always labelled as high risk devices. So they come under the class III devices, and in this case 
hospitals and healthcare providers don’t want to take any chances. So there is always a surplus of 
instruments that are provided. 
Patrick: There are so many lawyers hanging around you… 
Pranay: So everything is disposed of, when it comes to cardiology and neurology. And when you look at 
waste from operation theatres, that’s where most of the waste gets generated. 
Patrick: As you know, hospitals have got a lot of electronic stuff, a lot of it is actually external to the 
patient and its just like a mobile phone as far as recycling is concerned. So its not strictly a medical 
problem as such. I mean here in Australia you can send your old mobile phone by post for free and they 
say they say they’re gonna recycle it, and the same with our old computers. 
Look I don’t know if there is much else that I can tell you Pranay. I think you are doing a pretty good job, 
from all the angles, right? You’ve been researching this for one year, have you? 
Pranay: Yes, close to a year and a half. 
Patrick: But you have [] in the industry so you have hit the ground running as it were. 
Pranay: Actually that is where this research started, I graduated with a degree in product design and once 
you are a graduate you end up trying to find ways of using the concept of making as problem solving. 
And now we are realizing that this whole practice of making for the sake of making is leading to all of 
these concerns and then my work in the healthcare industry seemed to extrapolate that problem to another 
level where everything gets disposed of. So the concern was how my own practice was affecting all of 
this and that’s where the research actually began into understanding what kind of waste was being 
produced and why this was happening and how can designers change their practice. 
  
138 
Patrick: So you actually brought your topic to Stephen rather than Stephen suggesting the topic. That’s 
good, because its yours. There was one other question. Sterilization, is there any possible improvements 
there that could lead to reuse, do you know? 
Pranay: So right now the thing is, from a technological standpoint there are sterilization setups for most 
materials that get used in the healthcare industry, so whether you are looking at plastics… 
Patrick: Radiation for instance, for sterilization. 
Pranay: Yes, radiation as a sterilization method is good for plastics, ethylene oxide is good for plastics, 
hydrogen peroxide is also used. The problem is that it’s a capital investment that the hospitals will not go 
in for when they know that the supply chain for continuous plastic products is already in place and it 
working well. So, there is a misinterpretation of the value associated with medical products from the 
various stakeholders involved. So, what the nurse thinks of a product, and for a nurse, its just a headache 
to get products out, throw them and segregate them. 
Patrick: As long as there is no cost to them from waste recycle or resource depletion there is no reason for 
them to do it. You really need larger change in the economy. It’s the same with carbon dioxide emissions 
unless in fact carbon has a cost of some sort, then its not gonna happen. Look Pranay, I think you are 
doing a very good job, and I think you really know a lot more than I do and I’ve given you all that I can 
suggest. The topic needs to be developed further, and I wish you best of luck for that. 
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(ii) Interview with Gianpaolo Fusari 
GP: The problem with methodologies and frameworks is that it is difficult to understand when to apply 
them, and only experience can tell you, after you’ve tried a few, which will be appropriate for you now. 
But if I go back to when I was studying and when I was introduced to a few of these, that was a good time 
to understand the different options that are out there, and then as I started getting in to medical devices 
and a career in healthcare, all the methodologies have come my way and its just a mish-mash. So I can’t 
say that I do double diamond approach, I think everything fits into double diamond. Yeah, it goes beyond 
that, and its never linear. My first question to you is, is this an educational thing, or how do you expect 
this to be used in practice. That is number one. The second thing is, I think as a theoretical framework it is 
much more effective at highlighting the higher level aspects, so maybe as an influencer for policy, maybe, 
than it is for design practice. For design practice you probably need to, and maybe you already do, but, 
have more detailed steps. Design is, I think, more of a moment to moment kind of practice. So if you are 
in discovery mode, trying to understand what problem needs finding, you need to understand how to 
discover those problems. So how to observe, how to talk to people, how to be inquisitive. In order to do 
that, with this framework in mind, I would need to understand what is it that I am looking for in recycling, 
or how people dispose of things, or how they buy things. So maybe things like, in order to be a practical 
tool, it needs to be more detailed. So those are the main two things that I can see as a big overview. 
Pranay: So now if we just go back to the problem at large where we are generating too much waste, and 
everything seems to be in a cradle to grave process, and you are an expert in medical devices. So what is 
your opinion on that? 
GP: My opinion on that is, as a designer your hands are tied on what the regulations are. Even if you 
don’t want to, even if you go to the market, this is not single-use, this you can reuse many times, they 
don’t care. They are used to throwing it away, and they are expecting that, because it is safer for the 
patients. Because the penalties for infections, and all these never events are so high, that it makes the 
efforts to be risk averse, obviously, its fine to be risk averse in healthcare, but we take it to an extreme, 
where infection is this massive thing that everyone wants to avoid. We go all the way to an extreme to 
avoid that. Things like throwing everything away, using only once. So, going back to my point, even as a 
designer, if I want to introduce something there, I’m tied by the market and by the regulations, and by the 
mindset, I think. The buyer won’t listen to me, because they are not expecting that. So I really don’t know 
where to start, I think it needs a mind shift for everybody that needs to happen, and incentives need to be 
shifted I think. 
Pranay: One of the things I found in my study to understanding how we came up to this whole single use 
disposable model is that, in the 60s when the plastics explosion happened, before the 60s all medical 
devices were reusable. But then suddenly there was this boom in plastics because people found it cheaper 
and a lighter material which could be used for lots of different cases, and they started getting produced. In 
the beginning when plastic devices were made, they already came with what would be required to 
sterilize them, so that time we had ethylene oxide as the best sterilization method available, or 
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radiowaves, and the problem was that plastic was already quite cheap, and in hospitals, ethylene oxide 
systems were not there because the sterilization methods were too expensive, the sterilization methods 
were too expensive. So doctors were finding it easier to dispose of and buy new ones, and that’s when the 
market also realized that this is what was happening. 
GP: There was more money to be made as well. 
Pranay: Exaclty, cause you can keep making and keep disposing. But there is no proof that before the 60s, 
we had rates of reinfection because of poor sterilization and it’s a mindset shift which has happened, and 
it has now been almost 50 years since that happened. Now that’s the problem, you can’t design a shift in 
mindset. 
GP: Not from a medical device point of view, no. That is a policy level thing. That’s why I feel a bit 
hopeless. There is very little that we can do. We need a big brother to take us and say we can do it this 
way. 
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(iii) Interview with Dr. Xiaoyu Yan 
Due to a technical error, the transcription could not be recovered. The following paragraph provides an 
overview of the interview. 
The interview began with pleasantries and a brief introduction to the use of the framework and its 
purpose. Dr. Yan’s first and main concern was what was going to be measured or quantitatively evaluated 
through this framework. I explained how the framework is qualitative and provides the designer an 
understanding of potential circular strategies which could guide the design of the device. Dr. Yan pointed 
out that there should be a metric to compare concepts, which may be cost, carbon emissions, or a 
quantitative evaluation of circularity, like the material circularity index. As circular economy is a new 
field, there is still no circularity metric that establishes the advantages or disadvantages of circularity, or 
the different cycles that are used. I argued how carbon footprint is dependent on accurate data, which is 
still not very reliable. As circularity is novel and not quantifiable in itself as yet, it is not easy to sell. Cost 
is the most established and vital metric that determines the design that moves forward. Dr. Yan mentioned 
how measuring cost is unavoidable for determining the advantages of design, and since the UK govt has 
set carbon emission targets, carbon emissions is another aspect that must be factored, and the novel area 
for further research would be quantifying circularity. Thus an interesting next research phase could be 
quantifying circularity for medical devices. By having these three distinct evaluations of medical devices, 
it is possible to weigh one concept with another, to then provide the designers and clients with a variety of 
decisions to move forward with. Dr. Yan also pointed out how I was looking at circularity and carbon 
emissions simultaneously and they do not always support each other. Some circular options have higher 
emissions than non-circular ones, and so they must be determined as independent variables.  
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(iv) Interview with Jonathan West 
Jonny: It also depends on where design finishes. We redesigned a resuscitation trolley. One of my first 
jobs here. There were errors happening during resuscitation attempts. We redesigned a trolley to better 
define team roles to make resuscitation attempts run more smoothly, to improve access to consumables in 
emergency. The idea was to improve the process of resuscitation. The process is very clear and is not up 
for negotiation. So how do you improve the access to equipment and how do you define team roles. And 
we had a whole bunch of ideas. Two strong candidates were; One, garments. So the team each wear 
aprons that define team roles but also have within them some kit, so you just use the stuff and get going. 
The second one was a trolley redesign. So you stow a trolley somewhere, you wheel it to a site. The 
trolley in question split, so everybody had a little [] subtrolley, define your team role, you had your kit on 
it. That’s the one we went with. At that time, we were thinking where do we go next with this. The 
garment one didn’t get enough positive user feedback so we ditched that, it didn’t get past the usability 
stage. But had it got past, lets pretend that, you really get to the point where, what do we do next? You’re 
gonna have to either set up a company of our own to do this, or give it to an existing manufacturer to do 
it. So that would be either garment manufacturers who have NHS contracts and who don’t have to try to 
get themselves in on a known supplier, or trolley or equipment manufacturers. We ended up protecting 
and licensing and we did that sort of thing. But I think we are different. I use the word ‘we’ to include you 
or the sort of designers you’ve just talked about, cause you’ve got a free hand. If you were a trolley 
designer you would never have considered garments as an option. So, that’s the question about where 
does design end. We could’ve gone with a garment, we could’ve gone with a trolley. We basically went 
with what the users wanted best, or what would best tackle the problem and then went for that. Eco 
considerations weren’t on our agenda to be honest with you. This would help for sure. But if the 
ecologically best thing to do would be a new product typology which didn’t have a manufacturer or an 
easy route to market, what do we do with that? We don’t really know what to do? That’s not to say it 
shouldn’t be done, we shouldn’t try, but you’re faced with a certain number of options for enactment, or 
to create impact, otherwise, you’d run the risk of your designs sitting on the shelf and not benefitting 
anybody. So, how pragmatic are we? It might be that all the people queuing up to take your idea off your 
hand and commercialize it, they’re all bad ecologically. So you’ve got the least worst option. Which is 
fine, it might be a bit eco-efficiency kind of an argument. Whereas the eco-effective argument would be 
I’m not gonna hand my design over to any of you guys because you’re all bad on different levels. So 
we’re going to have to think of a new way of doing it. I would say that would go beyond design and start 
to be entrepreneurial. Depends on what is your definition of design, we’re talking about devices, right? 
Well then you start talking about service and system and procurement reconfiguring. I’m just running a 
position paper at the moment where I feel even setting aside the ecological case, I feel it’s a really hard 
job even in the first place for our side designers, not like an inhouse disposables or whatever, where 
manufacturer is willing to take up whatever they’ve done. If you’re knocking on doors trying to get 
somebody to take forward your design, its really hard in the first place to affect any grassroots or frontline 
initiated design. I’m not disagreeing with your work at all. I think it is right and proper we do exactly 
what you are saying. It would be great to live in a world where we do all the frontline research and all that 
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stuff, and all your options to hand it over, to commercialize are great. They’ve [] milk bottle reusable kind 
of stuff, they’re all good guys then you can it to them and you can sleep at night. Unfortunately no such 
thing exists, or atleast very few, especially the big players in the consumables cause they rely on scales 
and hospitals are addicted to cheap consumables, cause its cheap, and they don’t have to think about all of 
this. That is the simplest way forward because consumables just make you do that. Which is why that 
flow mark, the drip, that is basically trying to say, well we’ve got patient safety cases for improving 
accuracy of infusions. That, at the moment, is not solved because standard drips are terrible or solved by 
an expensive pump, which actually might have a lot of this, there is a lot of power used, training used, 
patient safety problems with that. And also, as well as the pump, you need the standard consumables. So 
what I’m trying to say was, forget the standard consumables, replace that with my consumable, so I guess 
its just as bad for the planet, but you’re not running it through this pump, which I guess in an order of 
magnitude, an amount of ecological impact. If you draw a boundary around the infusion process I guess 
I’m doing a bit of eco-efficiency design. 
Pranay: Because the solution is already there and you are reducing it, minimizing it. 
Jonny: Yeah, but it’s a little bit beyond the consideration of the product. You’re considering the clinical 
process. So you’re using one product to replace other products in that chain of delivering fluid into 
patients. What I find interesting about that is that you’re able to flex engineering muscles because you’re 
reducing part count and all of that sort of stuff. Its also very user centric. Fundamentally what you’re 
trying to get some fluid into a patient’s blood stream, and how is that done today. Its done with all these 
weird, wonderful and expensive, eco bad products. Then how can we streamline that. Possibly, I should 
be thinking less of how do we streamline it, but how do we circulify it. My solution is a disposable thing, 
and I can sleep at night because it replaces another disposable thing and it does away with other bad 
things. The ideal would be it gets rid of all the disposable things, and its nice and circular in some sort of 
way. The problem is, I’m trying to make this real, and my options at the moment are, big consumables 
manufacturers that also make pumps right, so got an up hill struggle, because they don’t want to 
cannibalize pump sales. If I came up with some sort of glass, or non-PVC flexible polymer or a natural 
equivalent of that, its nice and recyclable and recoverable and all that, that would be brilliant. 
Unfortunately, I don’t know any manufacturer that currently makes that who would do the scales at would 
make it competitive and who would see the value in it. I’m just trying to lay out my thinking as well. 
I think what I’m trying to get at is that this model can help you decide where your design might go, but 
where the design is handed over then to somebody to implement is crucial because those implement 
actors are largely not thinking about this at all and just want to make money out of it. And I don’t think 
that’s a bad thing because your product has to make money for somebody somewhere because otherwise 
it can’t exist. What I maybe think is that we need your model, for us but also for the chief operators level 
of corporates who would take a strategic view of this, and think where can my multinational behemoth 
generate value. Because at the moment we are basically doing [extraction, manufacture, assembly and 
procurement] and that’s where the money is. There are probably separate companies doing recovery and 
all that. Or they move to a sort of rental model maybe there’s more eco stuff in that. As well as 
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influencing the strategy of the big companies they’re only going to listen to who is paying them. So the 
hospitals are going to say, its crazy that all our nurses are throwing stuff away because we are making 
more problems for the recovery people. It might be easier for the nurse but its harder there. [] They don’t 
really care about saving elsewhere, so how do you join up that. So I guess that your model is true, I can’t 
see any problem with the model. I think its where do responsibilities end. Where designer’s 
responsibilities and where next with your design. Because at the end of the day we want to get our things 
to the front line. 
Pranay: What you started with, “Where does design end?” is true because this pushes it not just to 
designing the product but designing the lifecycle. So you’re effectively designing a system, and then 
trying to fit it in a bigger system and to find financial leverage as well as get all the stakeholders on board. 
It is obviously a mammoth task and there are too many risks involved. Ofcourse that is a consideration. 
So this came out of a purely theoretical understanding of the field, both the theory of the practice that 
exists and the theory of the policy that exists. So this is the ideal state, and from here on its just about how 
do you get it to be more practical. 
Jonny: Yes, but I wouldn’t compromise it on its journey towards practicality and implementation. I just 
think, I guess, know your audience. I think your illustration of the urinal or the implantable, that’s really 
good because there might be certain circumstances where we would have a suite of ideas and the users, 
maybe it’s a draw, we can’t decide, I would say here the user trumps, because if its not going to work then 
whats the point in doing. Then if you’ve got a number of strong candidates that would do the job 
effectively, whatever you’re trying to solve, and you can’t decide, and actually its not clear downstream 
who the actors are going to be to take your idea forward, then this is going to be great right because you 
could say which is best for the polar bears, and that would mean, hopefully when attitudes have changed 
enough, you can say, when you go and try to sell your idea to a manufacturer you can say well this comes 
with all these eco credentials, its good for your image. 
Pranay: Yeah I think that is probably how it will happen. In any situation, you can’t trump user, and you 
can’t trump usability, but beyond that everything is a question. 
Jonny: Yes, but also, I am acutely aware that me, our gang, who are all on holiday, we have a free hand 
when we start our projects, it might be very different. I don’t know if you have spoken to any in house 
people. Because they want to do something about creatinine, but they sell millions of catheters, so they 
can’t do an information redesign, or something to do with urinals, which is like not got a business so 
they’re just not interested. It would be interesting to know how constrained those people feel. So we’re 
not constrained, but we’re just constrained by realism. We have a nice open front-end to the innovation, 
and then when we’ve got a good candidate to solve problems, well then pass it on to somebody who can 
make it work, cause that’s all we do. The problem is those people whom we pass it on to don’t really 
think along these lines, unless they make money. Another thing you could be interested in is Innovation 
RCA. Because they’re setting up new businesses, and new business models, that means their thinking 
might be more fluid to this. It might be that healthcare is just sort of stuck in its ways with regards to 
devices, but even that’s changing with all this data and digital stuff. 
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Pranay: It is, its becoming fluid as to what is a product. We don’t know anymore. Which is one of the 
things that happen with bioabsorbable devices. Many of these bioabsorbable devices also have drugs in 
them which are transported by the device and act in some part of the body. So technically it not just has a 
physical therapeutic effect on the body but also has a chemical therapeutic effect on the body. So is it a 
drug or is it a medical device, because it is degrading in the body anyway. So its very unclear as to how 
you even segregate all of these devise and classify them. 
Jonny: For example, virtual reality treatment for psychosis. It has been CE marked as a medical device. 
Cause you’re wearing it. 
Pranay: So the headset is a medical device. 
Jonny: Well yeah, you can use a number of different headsets. It’s the actual treatment. So the scenario is 
that you go through the tasks and that sort of thing. 
Pranay: So that’s a medical device. Actually a software can be a device. You can mark it a software 
separately. So I have a few questions and I think you have answered most of them. So if you have any 
other comments. 
Jonny: I think I understand the framework, thank you for taking the time. Yeah you have drawn on really 
good stuff. Before I met you today, I was interested in trying to create a project around looking at a 
treatment and understanding its use in its entirety. Because I think big manufacturers, they see this, but 
they’re siloed in their thinking. So they think, we make bags of fluids, drips, tubes, and pumps and 
needles and we want to make each of those components better. I don’t think they’re looking at that as a 
whole. So we’d get a number of different candidates, and some of them might be green or not, and some 
of them might actually be eco-effective. So can we do that. And what would be a good clinical process for 
doing that. 
Pranay: Actually, one of the examples of this framework is, the example that I showed, you have a need, 
and you need to develop new products for it. So you’re at the stage of developing ideas, and then you’re 
at the stage of evaluating them so you can use this to figure out where do you want to go. The other is, 
you already have a product, you make these products, and you don’t know how do you make them better. 
So, can you use this to evaluate the product itself, on how its being used today, and then see is there 
another cycle available. 
Jonny: Where that thinking meets my thinking is considering it’s a clinical system, and not just an 
isolated product. So you probably have to do numerous product analyses, and then try to zoom out and 
see, can these discrete products be replaced in any way, ideally with small number of products. It might 
even be that they are a bigger number of products, but they are eco-effective rather than efficient, and that 
would still be better. The question is what is a good candidate clinical process to start with. Maybe we 
should start with dialysis, that might be good. 
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Pranay: Dialysis is great. Actually nephrology is great. The thing about the kidneys is, most of the 
problems are asymptomatic, so that means you have to get tests done to know what is wrong with you. 
The only symptom you show is fatigue, and sometimes water retention. Most people let that water 
retention be just like, I am growing fat, or something. For every test, you are going to use some diagnostic 
tool, and for all the treatment, if its dialysis, everything gets chucked out and new things come in. So 
there is a huge amount of waste produced, and it is a long term problem. Kidney disease lasts 10-15 years, 
and after that you die. So you don’t survive it. So even if you have a kidney transplant, you probably have 
10 years to live. So yeah, there is a huge amount of waste produced in nephrology, So its actually a 
perfect place to start. The other options are cardiology and neurology, but those are too sensitive. You 
can’t go wrong over there otherwise you will kill the patient. Nephrology is actually good. 
Jonny: To finish off your questions. One of the problems that I have with what we do is, historically we 
have not been good at implementing designs and for a semi academic institution, that’s not a killer, 
because we can still get research council funding, we demonstrate impact just by telling people how great 
our work is. But my personal ambition is I want us to do more impact, right. And to do impact, we have 
to rely on people. If we didn’t have that part of it, I would be totally signed up for this. Because you can 
do a lot of talks to everybody and say I have designed the best, greenest recyclable everything, reusable 
everything. The problem with consultancies is that they get commissioned to do this, and therefore have 
boundaries. 
Pranay: They can suggest, but they are not in line for implementation 
Jonny: Most of their clients would be like, a farmer, or a device manufacturer, so they’d have to do 
something a device manufacturer can make and realise value from. But maybe I’m being inaccurate. I’m 
sure they also get commissioned for strategic pieces. It might be that Smiths medical are fed up from 
coining it from their devices and want to move to a service. I’m sure they’d be like, I can make money out 
of data. So they’ll need somebody to look at that for them. 
I think user and income comes first, but if you’ve got candidates then it should be second in the mix. Or 
maybe third in the mix. The second is, who are we going to pass this on to. What is the strategy. 
Pranay: So user comes first. 
Jonny: User comes first. You’ve got 10 ideas, five of which actually solve the problem or users will 
accept. And then I would say, the next filter might be what vehicles do we have for implementation. 
That’s I think where we start to go down the dark road. If from the five that are left, three of them are 
strong candidates, and we use your model, and there’s one left in the mix that is good, then ofcourse we 
take this one. 
Pranay: Yeah, it makes sense. Unless it is a priority, its not going to go up. So for example, unless the 
government imposes policies, which enforce more sustainability, then this is always going to get pushed 
down in the priority list. 
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Jonny: Actually, maybe I’m too gung-ho in trying to make a difference. It might be that, we either try a 
proper clinical problem, we’ve got some solutions that users say will definitely work, we’re getting 
somewhere. And then my only candidates are bad for the planet. If you were to offer me a calculus that 
would say, Jonny of your five concepts, I can give you a calculation that will say it will save this many 
lives, but it will make sea levels rise by this amount or some sort of negative. If you can quantify that 
against the user benefit, and it quickly turns out that all my five are net bad, then I shouldn’t go forward. 
Even if three are really strong candidates making a difference to the patient. Unless you can make it 
reusable, recyclable, and find a candidate that can help you take it forward and demonstrate that with the 
trade off. Cause you’re looking for patient benefit really, the down side is eco-impacts. Its patient safety 
or costs, it’s a classic climate change problem, we could bend over backwards, so we’re carbon neutral, or 
we don’t put plastic in the sea, but we’ve compromised our thing, so its like a nominal patient benefit, but 
atleast we’ve done the eco-green thing. But then America sells a million happy-meal plastic toys. 
Pranay: Eventaully there is going to be a resource shortage, if we continue using the resources we are 
using at today’s level. That’s when these sort of things get ingrained in company policy or national 
policy. Then its all about how do companies shift or transition to that space where the polar bears have to 
be given the same weight as… 
Jonny: Can you not shortcut that. Its cheaper to buy a tesla than a ford. Or wind turbines or solar panels 
will generate for the same price. If we as designers churn out eco-effective stuff that licencees or whoever 
we are handing it over to, they’ve got such a better business case than disposables. 
Pranay: That’s actually where I want to take my PhD. This is the first point. You need to prove that there 
are alternative options to disposables. If you have those options, how do you make them financially 
viable. That’s is the next stage. For that I need to build case studies, and show the financial benefits. 
Jonny: I’m just trying to think of big consumables. They make billions of these units. We come up with a 
new widget that is not made out of plastic. Its made out of something else that does the job. They’re 
unlikely to take it, because it cannibalizes their products. So you have to go to somebody who is going to 
disrupt. But then you need the evidence, you need the sales network, you need the clinical case. But its 
great if you can do that. That’s the shape of things to come, for sure. If these huge companies keep 
making money out of plastic disposables. 
Its also to do with the appetite for change. I’m pragmatic enough, and patient enough that, I want to see 
change and therefore, if I look at a problem on a ward, instead of thinking of coming up with something 
new, I would return to that. I would look at using an existing device, and redesign that to affect the 
clinical benefit I am trying to achieve. That plays the status quo, but still gives you patient benefit. The 
big thing that it has in its advantage ecologically is that the very establishment of something new which is 
kind of inherent with the problem of design, you always want to do something new. I’m fighting against 
that because I think the biggest challenge we face in terms of implementation is that procurement doesn’t 
change, it buys what its always bought so its just gonna get what its always got. If you go into a ward, you 
see stuff. When I was a younger designer, I’d look at stuff in the ward and go why is it like this, its 
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rubbish, there’s lots of user problems, no wonder there everything’s going wrong. And then, as you do 
this enough times, you have a grudging respect for the thing that’s there, because actually its answered a 
lot of downstream questions that we don’t see. Now I look at it, and I feel those downstream questions are 
so hard to solve, that in fact I see these things in the ward as conduits or vehicles of change and actually 
you can use that as a sort of Trojan horse. So you redesign a things that’s always been there, but when its 
now being used, the new version of this has a sort of extra clinical merit. And actually if you do that a 
number of times, you can transform the ward into something safer. Its eco-efficiency, its looking at 
effecting change by pulling on the levers that already exist rather than inventing a new thing which is 
probably more damaging to the planet. Unless you do it your way. 
Pranay: Actually most of our technological cycles do go about the efficient route till you’ve absolutely 
reached the end, the technological end of a certain paradigm, and that’s when you completely change 
tracks. So for example, the concept of artificial intelligence has been there since the 60s and 70s, of how 
we could transfer knowledge and use a separate system to analyse it. But then its only when you see the 
financial benefits of it, and when you’ve sufficiently escaped computing power to a point where, you need 
someone to handle thinking beyond you. That’s when this sudden disruption happens. And then 
everyone’s gung-ho on it. 
Jonny: So whats the tipping point for consumables. 
Pranay: If there is a financial outcome from this, or any circular model, if it shows significant financial 
advantage to single-use disposables, then its gonna come in. 
Jonny: Maybe we also shouldn’t be looking at the companies. 
Pranay: Yeah, its probably going to be a disruption 
Jonny: Have you looked at the financial flow of waste services in hospitals? 
Pranay: Not yet. 
Jonny: Because if there is a way of hospital procurement understanding the outlay for recovery or 
whatever the back end of these circles is. The cost of that, versus the cost of that, and its joined up, and 
you understand how all that works, there’s probably a way then. This is probably an MBA kind of 
analysis. An understanding of monetary flow is key to it. While we collectively might have the skills to 
design products of the right material choice and all that, its like where is the value and who are we selling 
it to, and what volumes and what margins and all that stuff of which is something that I’ve only got [] 
knowledge about. 
Pranay; Yeah it comes down to the finances, if you want to implement it and take it out from academic 
knowledge and take it to practical knowledge, you have to figure out the finances. And, its all about 
cracking the value of the resources and the product in different flows to understand whether it makes 
sense to just dump it, or to keep extracting value from it. In other industries they’ve already seen that 
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value. So they know that, in the automotive industry, the resale market works much better than the new 
market. This decontamination challenge, and this challenge of killing people, even though the automotive 
industry kills a huge number of people every year, its not the same challenge. So this is a slightly different 
battle. One of the things I wanted to do was an inventory analysis, just to understand how many products 
and coming in and getting disposed, how many are going back for reprocessing and what is the value 
associated with the flows that are existing today, and then if you take one product, and put it into one of 
these cycles, then how does that value change, and that itself gives you an answer of whether the business 
is feasible or not. It might be feasible for certain products, it might not be feasible for others, but if it is 
feasible for certain products, then why wouldn’t companies go about it? 
Jonny: Yeah, I think that the problem is that the big companies of the world have sales reps that go to 
clinicians, not to waste disposal companies. But that doesn’t mean its not the right thing to do, that’s 
where the disruption is. If you can ensure that the clinical case is atleast as good, it doesn’t create all these 
downstream problems then. Yeah, it would be interesting to hear what your findings are. 
  
150 
List of References/ Cited Text 
1 Introduction 
Ahmadi, E., Masel, D. T., Metcalf, A. Y., & Schuller, K. (2018). Inventory management of surgical 
supplies and sterile instruments in hospitals: a literature review. Health Systems 8 (2), 134-151. 
Bouthors, C., Nguyen, J., Durand, L., Dubory, A., Raspaud, S., & Court, C. (2019). Single-use versus 
reusable medical devices in spinal fusion surgery: A hospital micro-costing analysis. European Journal of 
Orthopaedic Surgery and Traumatology 29 (8), 1631-1637. 
Braungart, M., McDonough, W., & Bollinger, A. (2007). Cradle-to-cradle design: creating healthy 
emissions – a strategy for eco-effective product and system design. Journal of Cleaner Production 15 (13-
14), 1337-1348. 
Caloyeras, J. P., Kanter, M. H., Ives, N. R., Kim, C. Y., Kanzaria, H. K., Berry, S. H., & Brook, R. H. 
(2018). Understanding Waste in Health Care: Perceptions of Frontline Physicians Regarding Time Use 
and Appropriateness of Care They and Others Provide. The Permanente Journal 22, 17–176. 
Eckelman, M., J. & Sherman, J. (2016). Environmental Impacts of the U.S. Health Care System and 
Effects on Public Health. PLoS ONE 11 (6). [online] Retrieved from: 
https://doi.org/10.1371/journal.pone.0157014 
Eckelman, M. J., & Sherman, J. (2018). Estimated Disease Burden From US Health Care Sector 
Greenhouse Gas Emissions. American Journal of Public Health 108 (S2), S120-S122. 
Ehrenfeld, J. R., (2005). Eco-efficiency Philosophy, Theory and Tools. Journal of Industrial Ecology, 
Vol. 9(4), pp. 6-8. 
Fernando, L., & Evans, S., (2016). Competencies to move beyond eco-efficiency. Procedia CIRP 40, pp. 
365-371. 
Frei, M., & Züst, R. (1997). The Eco-effective Product Design - The Systematic Inclusion of 
Environmental Aspects in Defining Requirements. Life Cycle Networks, pp. 163–173. 
Hawkes, N. (2012). Cutting emissions by drug industry is crucial to reducing NHS’s carbon footprint. 
BMJ 2012, 345. 
Hoenich, N. A., Levin, R., & Pearce, C. (2012). Clinical Waste Generation from Renal Units: 
Implications and Solutions. Seminars in Dialysis 18 (5), 396-400. 
Ison, E., & Miller, A., (2000). The use of LCA to introduce life-cycle thinking into decision-making for 
the purchase of medical devices in the NHS. Journal of Environmental Assessment Policy and 
Management, Volume 2(4), pp. 453-476. 
  
151 
Jeswiet, J., & Hauschild, M., (2005). EcoDesign and future environmental impacts. Materials and Design, 
Vol. 26, pp. 629-634. 
Kumar, M., Srai, J. S., & Minakata, Y. (2017). Industrial System Dynamics for Environmental 
Sustainability: A case study on the UK Medical Technology sector. International Journal of 
Manufacturing Technology and Management (IJMTM), Vol. 31(1), DOI:10.1504/IJMTM.2017.082024 
Kumar, P. A., (2014). Insulin Management System for Diabetic Patients. In: India HCI 2014 Conference 
on Human Computer Interaction. [online] New Delhi: ACM Digital Library, pp. 102-107. 
Kumar, S., & Putnam, V. (2008). Cradle to cradle: Reverse Logistics strategies and opportunities across 
three industry sectors. International Journal of Production Economics, Vol. 115, pp. 305-315. 
legislation.gov.uk (2008), Climate Change Act 2008, Chapter 27. Retrieved from 
http://www.legislation.gov.uk/ukpga/2008/27 
Minoglou, M., Gerassimidou, S., Komilis, D., (2017). Healthcare waste generation worldwide and its 
dependence on socio-economic and environmental factors. Sustainability, Volume 9 (2), p. 220. 
NHS England (2018). Reducing the use of natural resources in health and social care. Sustainable 
Development Unit, Cambridge. Retrieved from: https://www.sduhealth.org.uk/policy-
strategy/reporting/natural-resource-footprint-2018.aspx 
Ramani, K., Ramanujan, D., Bernstein, W. Z., Zhao, F., Sutherland, J., Handwerker, C., Choi, J. K., Kim, 
H., & Thurston, D. (2010). Integrated Sustainable Life Cycle Design: A Review. Journal of Mechanical 
Design 132 (9). 
Shuman E. K., & Chenoweth, C. E., (2012). Reuse of Medical Devices: Implications for Infection 
Control. Infectious Disease Clinics of North America 26 (1), 165-172. 
Thorlby, R. (2013). Reclaiming a population health perspective. Nuffield Trust: London, UK. 
Ryn, S.V.D. & Cowan, S., (1996). Ecological Design. Island Press, Washington. 
Sinucare.in (2017). SinuCare. [online] Available at: http://www.sinucare.in/ [Accessed 28 Aug. 2019] 
Windfeld, E., S. & Brooks, M., S. (2015). Medical waste management - a review. Journal of 
Environmental Management 163, 98-108. 
Zygourakis, C. C., Yoon, S., Valencia, V., Boscardin, C., Moriates, C., Gonzales, R., Lawton, M. T., 
(2016). Operating room waste: disposable supply utilization in neurosurgical procedures. Journal of 
Neurosurgery 126, 620-625. 
  
152 
2 Literature Review 
Abukhader, S. M., (2008). Eco-efficiency in the era of electronic commerce - should ‘Eco-Effectiveness’ 
approach be adopted?. Journal of Cleaner Production, Vol. 16, pp. 801-808. 
Alexander, K., Clarkson, J., Bishop, D., and Fox, S., (2001). Good Design Practice for Medical Devices 
and Equipment - A Framework. University of Cambridge, Great Britain (2001) 
Backer, L. & Clark, T. S. (2008). Eco-Effective Greening Decisions and Rationalizations. Organization & 
Environment, Vol. 21(3), pp. 227-244. 
Bakker, C., Wang, F., Huisman, J., & Hollander, M. D. (2014). Products that go round: exploring product 
life extension through design. Journal of Cleaner Production 69, 10-16. 
Bakker, C. A., Wever, R., Teoh, C. & De Clercq, S. (2010) Designing cradle-to-cradle products: a reality 
check, International Journal of Sustainable Engineering, Vol. 3(1), pp. 2-8, 
DOI:10.1080/19397030903395166 
Bhamra, T. A., Evans, S., McAloone, T. C., Simon, M., Poole, S., & Sweatman, A. (1999). Integrating 
Environmental Decisions into the Product Development Process: Part 1 The Early Stages. Proceedings 
First International Symposium on Environmentally Conscious Design and Inverse Manufacturing, Tokyo, 
Japan (1999). DOI: 10.1109/ECODIM.1999.747633 
Bjørn, A., & Hauschild, M. Z. (2012). Absolute versus Relative Environmental Sustainability. Journal of 
Industrial Ecology, Vol. 17(2), pp. 321-332.  
Braungart, M., McDonough, W., & Bollinger, A. (2007). Cradle-to-cradle design: creating healthy 
emissions – a strategy for eco-effective product and system design. Journal of Cleaner Production 15 (13-
14), 1337-1348. 
Ehrenfeld, J. R., (2005). Eco-efficiency Philosophy, Theory and Tools. Journal of Industrial Ecology, 
Vol. 9(4), pp. 6-8. 
Fernando, L., & Evans, S., (2016). Competencies to move beyond eco-efficiency. Procedia CIRP 40, pp. 
365-371. 
Frei, M. (1998). Eco-effective product design: the contribution of environmental management in 
designing sustainable products. The Journal of Sustainable Product Design, Vol. 7, pp. 16-25.  
Frei, M., & Züst, R. (1997). The Eco-effective Product Design - The Systematic Inclusion of 
Environmental Aspects in Defining Requirements. Life Cycle Networks, pp. 163–173. 
Hauschild, M. Z., (2015). Better - but is it good enough? On the need to consider both eoc-efficiency and 
eco-effectiveness to gauge industiral sustainability. Procedia CIRP 29, pp. 1-7. 
  
153 
Kumar, M., Srai, J. S., & Minakata, Y. (2017). Industrial System Dynamics for Environmental 
Sustainability: A case study on the UK Medical Technology sector. International Journal of 
Manufacturing Technology and Management (IJMTM), Vol. 31(1), DOI:10.1504/IJMTM.2017.082024 
Kumar, S., & Putnam, V. (2008). Cradle to cradle: Reverse Logistics strategies and opportunities across 
three industry sectors. International Journal of Production Economics, Vol. 115, pp. 305-315. 
Medina L. A., Kremer, G. E. O., & Wysk, R. A., (2013). Journal of Engineering Design. Vol. 24(2), pp. 
83-119. 
Niero, M., Hauschild, M. Z., Hoffmeyer, S. B., & Olsen, S. I. (2017). Combining Eco-Efficiency and 
Eco-Effectiveness for Continuous Loop Beverage Packaging Systems. Journal of Industrial Ecology, Vol. 
21(3), pp. 742-753. 
Ocampo, J. U., & Kaminski, P. C., (2019). Medical device development, from technical design to 
integrated product development. Journal of Medical Engineering and Technology, Vol. 43(5), pp. 287-
304. 
Pietzsch, J. B., Shluzas, L. A., Pate-Cornell, M. E., Yock, P. G., Linehan, J. H. (2009). Stage-Gate 
Process for the Development of medical Devices. Journal of Medical Devices, Vol. 3, pp. 021004-1 - 
021004-15. 
Rossi, M., Germani, M., & Zamagni, A. (2016). Review of ecodesign methods and tools. Barriers and 
strategies for an effective implementation in industrial companies. Journal of Cleaner Production, Vol. 
129, pp. 361-373. 
Ryn, S.V.D. & Cowan, S., (1996). Ecological Design. Island Press, Washington. 
Santos, I. C. T., Gazelle, G. S., Rocha, L. A., Tavares, J. M. R. S., (2012). A dedicated methodology for 
the development of new medical technologies. The 2012 International Conference on Medical Physics 
and Biomedical Engineering. [online] Available at: https://repositorio-
aberto.up.pt/handle/10216/64386?mode=full 
Stahel, W. R., (1982). The Product-Life Factor. Ed: Orr, S. G., In: An Inquiry Into the Nature of 
Sustainable Societies: The Role of the Private Sector, the 1982 Mitchell Prizes Woodlands, TX: Houston 
Area Research Centre. 
Toxopeus, M. E., Koeijer, B. L. A. D., Meij, A. G. G. H. (2015). Cradle to Cradle: Effective Vision vs. 
Efficient Practice? Procedia CIRP 29, pp. 384-389. 
3 Methodology 
Blessing, L. T. M., & Chakrabarti, A., (2009). DRM, a Design Research Methodology. Springer (2009). 
[online] Available at: https://www.springer.com/gp/book/9781848825864#aboutAuthors 
  
154 
Hauschild, M. Z., (2015). Better - but is it good enough? On the need to consider both eoc-efficiency and 
eco-effectiveness to gauge industrial sustainability. Procedia CIRP 29, pp. 1-7. 
Kumar, M., Srai, J. S., & Minakata, Y. (2017). Industrial System Dynamics for Environmental 
Sustainability: A case study on the UK Medical Technology sector. International Journal of 
Manufacturing Technology and Management (IJMTM), Vol. 31(1), DOI:10.1504/IJMTM.2017.082024 
Kumar, S., & Putnam, V. (2008). Cradle to cradle: Reverse Logistics strategies and opportunities across 
three industry sectors. International Journal of Production Economics, Vol. 115, pp. 305-315. 
Murphy, R. (2012). Sustainability: A Wicked Problem. Sociologica 2/2012, 1-23. 
Patton, M. Q. (1990). Qualitative evaluation and research methods (2nd ed.). Sage Publications, Inc. 
Periyakoil, V. S. (2007). Taming Wicked Problems in Modern Healthcare Systems. Journal of Palliative 
Medicine 10 (3), pp. 658-659. 
Rittel, H. W. J., & Webber, M. M. (1973). Dilemmas in a General Theory of Planning. Policy Sciences, 
Vol. 4, pp. 155-169. 
Rossi, M., Germani, M., & Zamagni, A. (2016). Review of ecodesign methods and tools. Barriers and 
strategies for an effective implementation in industrial companies. Journal of Cleaner Production, Vol. 
129, pp. 361-373. 
Sevaldson, B., (2013). Systems Oriented Design: The emergence and development of a designerly 
approach to address complexity. Cumulus 2013, Oslo, Norway. [online] Available at: 
https://www.academia.edu/13300548/Proceedings_of_the_3rd_International_Conference_for_Design_Ed
ucation_Researchers_volume_1_ 
4 Phase 1 - Barriers and Opportunities to Eco-Effective Design for Medical 
Devices 
Alfa, M. J. (2019). Medical instrument reprocessing: current issues with cleaning and cleaning 
monitoring, American Journal of Infection Control, Vol. 47, pp. A10-A16. 
Azouz, S., Boyll, P., Swanson, M., Castel, N., Maffi, T., Rebecca, A. M., (2019). Managing barriers to 
recycling in the operating room. The American Journal of Surgery, Vol. 217, pp. 634-638. 
Bakker, C. A., Wever, R., Teoh, C. & De Clercq, S. (2010) Designing cradle-to-cradle products: a reality 
check, International Journal of Sustainable Engineering, Vol. 3(1), pp. 2-8, 
DOI:10.1080/19397030903395166 
Barbero, S., Pereno, A., & Tamborrini, P. (2017). Systemic innovation in sustainable design of medical 
devices. The Design Journal, 20:sup1, S2486-S2497, DOI: 10.1080/14606925.2017.1352763 
  
155 
Barbiroli, G., (2006). Eco-efficiency or/and eco-effectiveness? Shifting to innovative paradigms for 
resource productivity. The International Journal of Sustainable Development and World Ecology, Vol. 13, 
pp. 391-395. 
Bjørn, A., & Hauschild, M. Z. (2012). Absolute versus Relative Environmental Sustainability. Journal of 
Industrial Ecology, Vol. 17(2), pp. 321-332. 
Bouthors, C., Nguyen, J., Durand, L., Dubory, A., Raspaud, S., & Court, C. (2019). Single-use versus 
reusable medical devices in spinal fusion surgery: A hospital micro-costing analysis. European Journal of 
Orthopaedic Surgery and Traumatology 29 (8), 1631-1637. 
Chang, C. W. D., Brenner, M. J., Shuman, E. K., & Kokoska, M. S. (2018). Reprocessing Standards for 
Medical Device and Equipment in Otolaryngology: Safe Practices for Scopes, Speculums, and Single-Use 
Devices. Otolaryngology Clinics of North America, Vol. 52(1), pp. 173-183. 
Damha, G. L., Hofmann, A., Costa, D. G., & Hornos, J. M. (2019). How are end-of-life strategies adopted 
in the product-service systems? A systematic review of general cases and cases of medical devices 
industry. International Conference of Engineering Design 2019, Delft, The Netherlands. [online] 
Available at: https://www.cambridge.org/core/journals/proceedings-of-the-international-conference-on-
engineering-design/article/how-are-endoflife-strategies-adopted-in-productservice-systems-a-systematic-
review-of-general-cases-and-cases-of-medical-devices-
industry/7B08784FB8727B94E621D824D1E64C37 
Dept. of Health and Social Care, (2013a). Decontamination in primary care dental practices (HTM 01-
05). [online] Available at: 
https://www.gov.uk/government/publications/decontamination-in-primary-care-dental-practices 
[Accessed 29 Aug. 2019]. 
Dept. of Health and Social Care (2013b). Management and disposal of healthcare waste (HTM 07-01) 
Retrieved from https://www.gov.uk/government/publications/guidance-on-the-safe-management-of-
healthcare-waste 
Dept. of Health and Social Care, (2014). Health technical memoranda. [online] Available at: 
https://www.gov.uk/government/collections/health-technical-memorandum-disinfection-and-sterilization 
[Accessed 29 Aug. 2019] 
Dept. of Health and Social Care, (2016a). Decontamination of Surgical Instruments (HTM 01-01). 
[online] Available at: 
https://www.gov.uk/government/publications/management-and-decontamination-of-surgical-instruments-
used-in-acute-care [Accessed 29 Aug. 2019]. 
Dept. of Health and Social Care, (2016b). Decontamination of linen for health and social care (HTM 01-
04). [online] Available at: 
  
156 
https://www.gov.uk/government/publications/decontamination-of-linen-for-health-and-social-care 
[Accessed 29 Aug. 2019]. 
Dept. of Health and Social Care, (2016c). Management and decontamination of flexible endoscopes 
(HTM 01-06). [online] Available at: 
https://www.gov.uk/government/publications/management-and-decontamination-of-flexible-endoscopes 
[Accessed 29 Aug. 2019]. 
Dettenkofer, M., Grieûhammer, R., Scherrer, M., & Daschner, F. (1999). Life-Cycle Assessment of 
single-use versus reusable surgical drapes (cellulose/polyethylene - mixed cotton system), Chirug, Vol. 
70, pp. 485-492. 
European Commission (2012). DIRECTIVE 2012/19/EU OF THE EUROPEAN PARLIAMENT AND 
OF THE COUNCIL of 4 July 2012 on waste electrical and electronic equipment (WEEE). European 
Commission, [online] Available at: https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX:32012L0019 
European Commission, (2017). Regulation (EU) 2017/745 of the European Parliament and of the 
Council. Available at: https://ec.europa.eu/growth/sectors/medical-devices/new-regulations_en. pp. 
L117/1-L117/175. [Accessed 28 Aug. 2019] 
Eze, S., Ijomah, W., & Wong, T. C., (2019). Accessing medical equipment in developing countries 
through remanufacturing. Journal of Remanufacturing 9, 207-233 
Fernando, L., & Evans, S., (2016). Competencies to move beyond eco-efficiency. Procedia CIRP 40, pp. 
365-371. 
GAO (2008). REPROCESSED SINGLE-USE MEDICAL DEVICES. [online] Washington: GAO. 
Available at: https://www.gao.gov/new.items/d08147.pdf [Accessed 2 Sep. 2019] 
Greene, V. (1986). Reuse of Disposable Medical Devices: Historical and Current Aspects. Infection 
Control 7 (10), 508-513. Retrieved from https://doi.org/10.1017/S0195941700065140 
Hede, S., Nunes, M., Ferreira, P., & Rocha, L. (2013). Incorporating sustainability in decision-making for 
medical device development. Technology in Society 35(4), 276–293. 
Herrmann, C., Blume, S., Kurle, D., Schmidt, C., & Thiede, S. (2015). The Positive Impact Factory - 
Transition from Eco-Efficiency to Eco-Effectiveness Strategies in Manufacturing. Procedia CIRP, Vol. 
29, pp. 19-27. 
Ison, E., & Miller, A., (2000). The use of LCA to introduce life-cycle thinking into decision-making for 
the purchase of medical devices in the NHS. Journal of Environmental Assessment Policy and 
Management, Volume 2(4), pp. 453-476. 
  
157 
Jensen, J. P., Prendeville, S. M., Bocken, N. M. P., Peck, D., (2019). Creating sustainable value through 
remanufacturing: Three industry cases. Journal of Cleaner Production, Vol. 218, pp. 304-314. 
Kane, G. M., Bakker, C. A., Balkenende, A. R. (2018). Towards design strategies for circular medical 
products. Resources, Conservation and Recycling 135, 38-47. 
legislation.gov.uk (2008), Climate Change Act 2008, Chapter 27. Retrieved from 
http://www.legislation.gov.uk/ukpga/2008/27 
Markets and Markets (2016). Refurbished Medical Equipment Market (X-Ray, Ultrasound, MRI, CT 
Scanner, Nuclear Imaging Systems, Heart-Lung Machine, Surgical, CO2 Monitor, Patient Monitor, Pulse 
Oximeter, AED Defibrillator, Cath Labs, Neonatal, Endoscopy) - Global Forecast to 2021. Markets and 
Markets. Retrieved from: https://www.marketsandmarkets.com/Market-Reports/refurbished-medical-
devices-market-770.html 
McGain, F., McAlister, S., McGavin, A., & Story, D. (2010). The financial environmental costs of 
reusable and single-use plastic anaesthetic drug trays. Anaesthesia and Intensive Care, Vol. 38(3), pp. 
538-544. 
MHRA, (2016). Single-use medical devices: UK guidance on re-manufacturing. Pp.1-11. [online] 
Available at: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/534784
/Remanufacture_SUD_guidance.pdf [Accessed 28 Aug. 2019] 
MHRA, (2018). Single-use medical devices: implications and consequences of reuse. [online] pp.1-14. 
Available at: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/743416
/Single-use_medical_devices_implications_and_consequences_of_reuse.pdf [Accessed 28 Aug. 2019] 
Moultrie, J., Sutcliffe, L., & Maier, A. (2016). A maturity grid assessment tool for environmentally 
conscious design in the medical device industry. Journal of Cleaner Production 122, 252–265. 
Niero, M., Hauschild, M. Z., Hoffmeyer, S. B., & Olsen, S. I. (2017). Combining Eco-Efficiency and 
Eco-Effectiveness for Continuous Loop Beverage Packaging Systems. Journal of Industrial Ecology, Vol. 
21(3), pp. 742-753. 
Romli, A., Prickett, P., Setchi, R., & Soe, S. (2015). Integrated Eco-Design decision making for 
sustainable product development. International Journal of Production Research 53 (2), 549-571. 
Rutala, W. A., & Weber, D. J. (2016). Reprocessing semi-critical items: Current issues and new 
technologies. American Journal of Infection Control 44 (5), e53-e62. 
Sherman, J. D., Raibley, L. A. & Eckelman, M. J. (2018). Life CYcle Assessment and Costing Methods 
for Device Procurement: Comparing Reusable and Single-Use Disposable Laryngoscopes. Critical Care 
and Resuscitation, Vol. 127(2), pp. 434-443. 
  
158 
Shuman E. K., & Chenoweth, C. E., (2012). Reuse of Medical Devices: Implications for Infection 
Control. Infectious Disease Clinics of North America 26 (1), 165-172. 
Southworth, P. M. (2014). Infections and exposures: reported incidents associated with unsuccessful 
decontamination of reusable surgical instruments. Journal of Hospital Infection, Vol. 88, pp. 127-131. 
Stripple, H., Westman, R., & Holm, D. (2008). Development and environmental improvements of plastics 
for hydrophilic catheters in medical care: an environmental evaluation. Journal of Cleaner Production, 
Vol. 16, pp. 1764-1776. 
Thiel, C. L., Eckelman, M., Guido, R., Huddleston, M., Landis, A. E., Sherman, J., Shrake, S. O., Copley-
Woods, N., & Bilec, M. M. (2015). Environmental Impacts of Surgical Procedures: Life Cycle 
Assessment of Hysterectomy in the United States, Environmental Science & Technology, Vol. 49, pp. 
1779-1786. 
Unger, S. R., & Landis, A. E., (2014). Comparative life cycle assessment of reused versus disposable 
dental burs. International Journal of Life Cycle Assessment, Vol. 19, pp. 1623-1631. 
Unger, S., & Landis, A. (2016). Assessing the environmental, human health, and economic impacts of 
reprocessed medical devices in a Phoenix hospital’s supply chain. Journal of Cleaner Production 112, 
1995–2003. 
Unger, S. R., Hottle, T. A., Hobbs, S. R., Thiel, C. L., Campion, N., Bilec, M. M., & Landis, A. E. 
(2017). Do single-use medical devices containing biopolymers reduce the environmental impacts of 
surgical procedures compared with their plastic equivalents? Journal of Health Services Research & 
Policy, Vol. 22(4), pp. 218-225. 
Windfeld, E., S. & Brooks, M., S. (2015). Medical waste management - a review. Journal of 
Environmental Management 163, 98-108.  
5 Phase 2 - Mapping Material Flows in Medical Device Lifecycles 
Bjørn, A., & Hauschild, M. Z. (2012). Absolute versus Relative Environmental Sustainability. Journal of 
Industrial Ecology, Vol. 17(2), pp. 321-332. 
Bringezu, S., & Moriguchi, Y., (2002). Material Flow analysis. Eds. Ayres, R. U., & Ayres, L. W., In: A 
Handbook of Industrial Ecology, Edward Elgar, Cheltenham, UK. 
Dept. of Health and Social Care (2013b). Management and disposal of healthcare waste (HTM 07-01) 
Retrieved from https://www.gov.uk/government/publications/guidance-on-the-safe-management-of-
healthcare-waste 
Dept. of Health and Social Care, (2016a). Decontamination of Surgical Instruments (HTM 01-01). 
[online] Available at: 
  
159 
https://www.gov.uk/government/publications/management-and-decontamination-of-surgical-instruments-
used-in-acute-care [Accessed 29 Aug. 2019]. 
European Commission (2012). DIRECTIVE 2012/19/EU OF THE EUROPEAN PARLIAMENT AND 
OF THE COUNCIL of 4 July 2012 on waste electrical and electronic equipment (WEEE). European 
Commission, [online] Available at: https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX:32012L0019 
European Commission, (2017). Regulation (EU) 2017/745 of the European Parliament and of the 
Council. Available at: https://ec.europa.eu/growth/sectors/medical-devices/new-regulations_en. pp. 
L117/1-L117/175. [Accessed 28 Aug. 2019] 
Ison, E., & Miller, A., (2000). The use of LCA to introduce life-cycle thinking into decision-making for 
the purchase of medical devices in the NHS. Journal of Environmental Assessment Policy and 
Management, Volume 2(4), pp. 453-476. 
Lu, B., Zhang, J., Xue, D., Gu, P., (2011). Systematic Lifecycle Design for Sustainable Product 
Development, Concurrent Engineering: Research and Applications, Volume 19(4), pp. 307-323. 
MHRA, (2016). Single-use medical devices: UK guidance on re-manufacturing. Pp.1-11. [online] 
Available at: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/534784
/Remanufacture_SUD_guidance.pdf [Accessed 28 Aug. 2019] 
MHRA, (2018). Single-use medical devices: implications and consequences of reuse. [online] pp.1-14. 
Available at: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/743416
/Single-use_medical_devices_implications_and_consequences_of_reuse.pdf [Accessed 28 Aug. 2019] 
Rouselle, S. D., Ramot, Y., Nyska, A., & Jackson, N. D. (2019). Pathology of Bioabsorbable Implants in 
Preclinical Studies. Toxicology Pathology 47 (3), 358-378. 
Royal Devon and Exeter, (2018). Decontamination Policy and Procedures. Royal Devon and Exeter 
Foundation Trust. [online] Available at: 
https://www.rdehospital.nhs.uk/docs/patients/services/infection_control/decontamination-policy.pdf 
[Accessed 2 Sep. 2019]. 
WHO (2016). Donation of medical equipment. WHO, Retrieved from 
https://www.who.int/medical_devices/management_use/manage_donations/en/ 
6 Principles of Eco-Effective Design for Medical Devices 
Ahlborg, U. G., Brouwer, A., Fingerhut, M. A., Jacobson, J. L., Jacobson, S. W., Kennedy, S. W., 
Kettrup, A. A. F., Koeman, J. H., Poiger, H., Rappe, C., Safe, S. H., Seegal, R. F., Tuomisto, J., & Berg, 
  
160 
M. V. D. (1992). Impact of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls on human 
and environmental health, with special emphasis on application of the toxic equivalency factor concept. 
European Journal of Pharmacology 228, 179-199. 
Ahmed, R. A., & Boyer, T. J. (2019). Endotracheal Tube (ET). StatPearls Publishing LLC. Retrieved 
from https://www.ncbi.nlm.nih.gov/books/NBK539747/ 
Bakker, C., Wang, F., Huisman, J., & Hollander, M. D. (2014). Products that go round: exploring product 
life extension through design. Journal of Cleaner Production 69, 10-16. 
Bocken, N. M. P., Pauw, I. D., Bakker, C., & Grinten, B. V. D. (2016). Product design and business 
model strategies for a circular economy. Journal of Industrial and Production Engineering 33 (5), 308-
320. 
Braungart, M., McDonough, W., & Bollinger, A. (2007). Cradle-to-cradle design: creating healthy 
emissions – a strategy for eco-effective product and system design. Journal of Cleaner Production 15 (13-
14), 1337-1348. 
Chiellini, F., Ferri, M., & Latini, G., (2011). Physical-chemical assessment of di-(2-ethylhexyl)-phthalate 
from poly (vinyl chloride) endotracheal tubes after applications in high risk new borns. International 
Journal of Pharmaceutics 409 (1-2), 57-61. 
European Commission (2008). Directive 2008/98/EC of the European Parliament and of the Council of 
19 November 2008 on waste and repealing certain directives. Off. J. Eur. Union L 312, 3-30. 
European Commission (2012). DIRECTIVE 2012/19/EU OF THE EUROPEAN PARLIAMENT AND 
OF THE COUNCIL of 4 July 2012 on waste electrical and electronic equipment (WEEE). European 
Commission, [online] Available at: https://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX:32012L0019 
Fernando, L., & Evans, S., (2016). Competencies to move beyond eco-efficiency. Procedia CIRP 40, pp. 
365-371. 
Frei, M., & Züst, R. (1997). The Eco-effective Product Design - The Systematic Inclusion of 
Environmental Aspects in Defining Requirements. Life Cycle Networks, pp. 163–173. 
Gimeno, P., Thomas, S., Bousquet, C., Maggio, A., Civade, C., Brenier, C., & Bonnet, P. (2014). 
Identification and quantification of 14 phthalates and 5 non-phthalate plasticizers in PVC medical devices 
by GC-MS. Journal of Chromatography B 949-950, 99-109. 
Kogevinas, M. (2001). Human health effects of dioxins: cancer, reproductive and endocrine system 
effects. Human Reproduction Update 7 (3), 331-339. 
MHRA, (2016). Single-use medical devices: UK guidance on re-manufacturing. Pp.1-11. [online] 
Available at: 
  
161 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/534784
/Remanufacture_SUD_guidance.pdf [Accessed 28 Aug. 2019] 
Moultrie, J., Sutcliffe, L., & Maier, A. (2015). Exploratory study of the state of environmentally 
conscious design in the medical device industry. Journal of Cleaner Production 108, 363-376. 
Smiths Medical (2019). Uncuffed Ivory PVC, Oral/Nasal Tracheal Tube. Retrieved from 
https://m.smiths-medical.com/products/airway-management/endotracheal-tubes/uncuffed-endotracheal-
tubes/uncuffed-ivory-pvc-oralnasal-tracheal-tube 
Unger, S. R., Hottle, T. A., Hobbs, S. R., Thiel, C. L., Campion, N., Bilec, M. M., & Landis, A. E. 
(2017). Do single-use medical devices containing biopolymers reduce the environmental impacts of 
surgical procedures compared with their plastic equivalents? Journal of Health Services Research & 
Policy, Vol. 22(4), pp. 218-225. 
Vallet, F., Eynard, B., Millet, D., Mahut, S.G., Tyl, B., & Bertoluci, G. (2013). Using eco-design tools: 
An overview of experts’ practices. Des. Stud. 34, 345–377. 
Yoon, S. Z., Jeon, Y. S., Kim, Y. C., Lim, Y. J., Ha, J. W., Bahk, J. H., Do, S. H., Lee, K. H., & Kim, C. 
S., (2007). The safety of reused endotracheal tubes sterilized according to Centers for Disease Control and 
Prevention Guideline. Journal of Clinical Anesthesia 19 (5), 360-364. 
7 Discussion 
Braungart, M., McDonough, W., & Bollinger, A. (2007). Cradle-to-cradle design: creating healthy 
emissions – a strategy for eco-effective product and system design. Journal of Cleaner Production 15 (13-
14), 1337-1348. 
Frei, M., & Züst, R. (1997). The Eco-effective Product Design - The Systematic Inclusion of 
Environmental Aspects in Defining Requirements. Life Cycle Networks, pp. 163–173. 
legislation.gov.uk (2008), Climate Change Act 2008, Chapter 27. Retrieved from 
http://www.legislation.gov.uk/ukpga/2008/27 
Annexure 2 
Moriarty, P. (2020). Curriculum Vitae. Academia. Available at: 
https://monash.academia.edu/PatrickMoriarty/CurriculumVitae 
Royal College of Art (2020a). Jonathan West. Available at: 
https://www.rca.ac.uk/more/staff/jonathan_west/ 
Royal College of Art (2020b). Gianpaolo Fusari. Available at: 
https://www.rca.ac.uk/more/staff/gianpaolo_fusari/ 
  
162 
University of Exeter (2020). Dr. Xiaoyu Yan. Available at: http://emps.exeter.ac.uk/renewable-
energy/staff/xy258 
 
 
